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Abstract 
 
 A new ergosterol analog, talarosterone (V) and a new bis-anthraquinone derivative 
(XII) were isolated, together with ten known compounds including palmitic acid (I), 
ergosterol-5,8-endoperoxide (II), ergosta-4,6,8(14),22-tetraen-3-one (III), cyathisterone 
(IV), and the anthraquinones emodin (VI), questinol (VII), citreorosein (VIII), fallacinol (IX), 
rheoemodin (X), and secalonic acid A (XI), from the ethyl acetate extract of the culture of 
the marine sponge-associated fungus Talaromyces stipitatus KUFA 0207. The structures 
of the previously undescribed compounds were established based on extensive 1D and 2D 
NMR spectral analysis, and in case of talarosterone (V), the absolute configurations of its 
stereogenic carbons were determined by X-ray crystallographic analysis. The structures of 
the previously reported compounds were elucidated by 1H and 13C NMR analysis as well as 
by comparison of their NMR data to those reported in the literature. Moreover, the 
stereochemistry of cyathisterone and secalonic acid A were also confirmed by X-ray 
analysis. The anthraquinones VI-X and secalonic acid A (XI) were tested for their anti-
obesity activity using zebrafish Nile red assay. Only citreorosein (VIII) and questinol (VII) 
exhibited significant anti-obesity activity while fallacinol (IX) and rheoemodin (X) were not 
active. Emodin (VI) and secalonic acid A (XI) caused toxicity (death) for all exposed 
zebrafish larvae after 24h. 
 
 
Keywords: Talaromyces stipitatus, Trichocomaceae, anthraquinones, bis-anthraquinone, 
ergosterol derivatives, secalonic acid A, anti-obesity, zebrafish Nile red assay 
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Resumo 
Do extrato de acetato de etilo da cultura do fungo marinho Talaromyces stipitatus 
KUFA 0207 foram isolados um novo derivado de ergosterol, talarosterona (V), e um novo 
derivado de bis-antraquinona, composto (XII), juntamente com outros dez compostos 
conhecidos incluindo ácido palmítico (I), ergosterol-5,8-endoperóxido (II), ergosta-
4,6,8(14),22-tetraen-3-ona (III), ciatisterona (IV), e as anthraquinonas: emodina (VI), 
questinol (VII), citreoroseina (VIII), fallacinol (IX), rheoemodina (X), e ácido secalónico A 
(XI). As estruturas da talarosterona (V) e de bis-antraquinona (XII) foram estabelecidas com 
base na análise espectral de RMN uni- e bi-dimensional, e no caso da talarosterona (V), as 
configurações absolutas dos carbonos estereogénicos foram determinadas pela análise de 
dados de cristalografia de raios-X. As estruturas dos outros compostos foram elucidadas 
através da análise dos respetivos espectros de RMN de 1H e 13C, bem como pela 
comparação com dados espectrais descritos na literatura. A estereoquímica das moléculas 
de ciatisterona (IV) e do ácido secanónico A (XI) foi também confirmada pela análise de 
dados de raios-X. Os compostos antraquinonas VI-X e o ácido secanónico A (XI) foram 
testados para avaliação da atividade anti-obesidade utilizando o ensaio de “zebrafish Nile 
red”. Apenas a citreoroseina (VIII) e o questinol (VII) exibiram atividade anti-obesidade 
significativa enquanto o fallacinol (IX) e a rheoemodina (X) não mostraram nenhuma 
atividade. Emodina (VI) e o ácido secalónico A (XI) mostraram toxicidade para o ensaio 
referido. 
 
 
Palavras-chave: Talaromyces stipitatus, Trichocomaceae, antraquinonas, bis-
antraquinona, derivados de ergosterol, ácido secalônico A, anti-obesidade, zebrafish Nile 
red assay 
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1. General Introduction 
 
1.1. Milestone of Natural Products 
 
 Natural Products are the small molecules produced by biological sources, some of 
which possess interesting chemical structures and biological activities (Rollinger et al., 
2008). Natural Products and their derivatives have been invaluable as a source of traditional 
medicines and natural poisons (Koehn and Carter, 2005; Larsen et al., 2005). The ancient 
medicines, including cannabis, opium, alcohol and mandrake were used to relieve pain. In 
the 1817, Friedrich Sertürner, a German pharmacist, effectively isolated morphine, the first 
active secondary metabolite used as an analgesic drug, from opium, the milky latex sap 
produced by cut seed pods of poppy (Papaver somniferum) (Hamilton and Baskett, 2000). 
In 1928, Alexander Fleming serendipitously discovered penicillin, the first antibiotic that 
saved millions of lives and revolutionized the pharmaceutical research. After the Second 
World War, most of the pharmaceutical companies started the massive screening of 
microorganism for new antibiotics. In 1990, around 80% of drugs were inspired by this 
revelation, including antibiotics (penicillin, erythromycin and tetracycline), antimalarials 
(quinine and artemisinin), anticancer (taxol and doxorubicin), anti-parasitic (avermectin) and 
immunosuppressant for organ transplants (cyclosporine and rapamycins) (Fleming, 1944; 
Li and Vederas, 2009). 
 
 
Figure 1. A: opium; B: structure of morphine; C: structure of penicillin V. (Ref: 
https://en.wikipedia.org/wiki/History_of_penicillin). 
 
Natural Products have been the single most productive source of leads for drug 
development. More than 100 Natural Product-derived compounds are currently in preclinical 
and clinical development. Most of them are derived from plants and microbial sources. In 
the microbial area, the main sources are fungi and terrestrial actinomycetes. In the last 
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decade, there was a growing interest in the samples from marine environments as a source 
of novel bioactive metabolites (Harvey, 2008). 
 
 
1.2. The Marine Environments and Bioactive Natural Products 
 
1.2.1. Relationship between Marine Environments and Bioactive Natural 
Products 
 
 Even though plants continue to be a major source of new drugs with 91 compounds 
in clinical trials in late 2007, marine organisms and cyanobacteria have been investigated 
in the last few decades (Wase and Wright, 2008). Approximately 70% of the earth’s surface 
are occupied by oceans, which are composed of enormous and complex biodiversity in the 
ecosystem. The marine environments are an important source for exploring bioactive 
natural products for pharmaceutical purposes. Due to special chemical and physical 
conditions in the marine environments, there are a great diversity of marine organisms 
which can produce a myriad of compounds with unique chemical structures. From the 
period of 1965-2014, about 25,700 new marine natural products have been discovered and 
characterized from several regions or oceans around the world (Blunt et al., 2016).  
 
 
Figure 2. All the collection areas for marine natural products discovery in 1965-2014. (Blunt 
et al., 2016). 
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Bioactive compounds from marine organisms might be the result of the special 
requirements of an organisms for surviving and adapting themselves to an extreme 
environment under the sea for the purpose of communication, reproduction and protection 
against predation, competition and infection (Firn and Jones, 2000). Interestingly, many of 
these compounds have not been found in terrestrial sources (Carte, 1996). Most of 
organisms in marine environments have been explored for their chemical compounds in 
potential industrial developments, including pharmaceuticals, cosmetics, nutritional 
supplements, fine chemicals and agrochemicals (Kijjoa and Sawangwong, 2004). 
 
 
1.2.2. Importance of Marine Natural Products 
 
 Although not many compounds from marine organisms are found in pharmaceutical 
applications when compared to those obtained from terrestrial plants, the marine organisms 
continue to provide important and interesting molecules which can be considered as leads 
for developments of drugs for many serious diseases (Schueffler and Anke, 2014). 
However, as a result of several marine natural products discovering initiatives, there are 
some drugs from marine organisms that have been approved for pharmaceutical uses or 
under clinical trials nowadays.  
 
The first marine-derived drug which is cytarabine (Cytosar-U®), was approved by the 
Food and Drug Administration (FDA) and European Medicines Agency (EMA) in 1969 and 
became available for clinical uses. Cytarabine is a synthetic pyrimidine nucleoside, which 
was originated from the Caribbean sponge Tethya crypyta. Cytarabine is a cytotoxic drug 
which is used for treatment of several types of leukemia (Lowenberg et al., 2011; Mayer et 
al., 2010). Later on, vidarabine (Vira-A®), a synthetic purine nucleoside that was also 
isolated from Tethya crypyta, received the FDA approval in 1976 as an antiviral drug. 
Vidarabine are currently obtained from Streptomyces antibioticus (Whitley et al., 1980). 
Ziconotide (Prialt®), a synthetic version of peptide ω-conotoxin, was originally isolated from 
the venom of cone snails. This drug was approved by FDA and EMA in 2004 and 2005 
respectively, for the use in chronic pain management (Schmidtko et al., 2010). In 2004, the 
first fish oil-derived product, omega-3 acid ethyl esters (Lovaza®) was approved by FDA for 
the treatment of patients with severe hypertriglyceridemia (Koski, 2008). The anticancer 
drug trabectedin (Yondelis®), also known as ecteinascidin-743 (ET-743), is a 
tetrahydroisoquinoline alkaloid originally isolated from a colonial tunicate Ecteinascidia 
turbinate that collected from the Caribbean and Mediterranean seas (Rinehart et al., 1990). 
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Trabectedin was approved in EU for patients with advanced tissue sarcoma, as well as with 
platinum-sensitive ovarian cancer (Newman and Cragg, 2014). Another marine-derived 
chemotherapeutic drug is eribulin mesylate (Halaven®) which is a synthetic derivative based 
on the structure of halichondrin B, a polyether macrolide isolated from the sponge 
Halichondria okadai (Hirata and Uemura, 1986). Halaven® was approved by FDA in 2010 
and EMA in 2011 for the treatment of patients with metastatic breast cancer (Verdaguer et 
al., 2013). Moreover, the antibody-drug conjugate, brentuximab vedotin (SGN-35; 
Adcetris®) was originally isolated from the sea hare Dorabella auricularia. Adcetris® was 
approved by FDA in 2011 for the treatment of patients with Hodgkin’s lymphoma and 
patients with systemic anaplastic large cell lymphoma (Senter and Sievers, 2012; Younes 
et al., 2012). 
 
Table 1. Marine-derived compounds in clinical development [adapted from Mayer et al. 
(2010) and Martins et al. (2014)]. 
Compound name Trademark 
Original 
organism 
Disease area 
Status 
2013 
Cytarabine, Ara-C Cytosar-U® Sponge Cancer Approved 
Vidarabine, Ara-A Vira-A® Sponge Antiviral Approved 
Ziconotide Prialt® Cone snail Neuropathic pain Approved 
Omega-3-acid 
ethyl esters 
Lovaza® Fish Hypertriglyceridemia Approved 
Trabectedin (ET-
743) 
(EU Registered 
only) 
Yondelis® Tunicate Cancer Approved 
Eribulin mesylate 
(E7389) 
Halaven® Sponge Cancer Approved 
Brentuximab 
vedotin (SGN-35) 
Adcetris® Sea hare Cancer Approved 
Iota-carrageenan Carragelose® Red algae Antiviral 
Over-the-
counter 
drug 
Soblidotin 
(TZT1027) 
NA Bacterium Cancer 
Discontinue
d 
Plitidepsin Aplidin® Tunicate Cancer Phase III 
Lurbinectedin NA Tunicate Cancer Phase II 
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Compound name Trademark 
Original 
organism 
Disease area 
Status 
2013 
DMXBA (GTS-21) NA Worm 
Cognition, 
Alzheimer’s 
Phase II 
Plinabulin (NPI-
2358) 
NA Fungus Cancer Phase II 
CDX-011 NA Sea hare Cancer Phase II 
Elisidepsin Irvalec® Mollusk Cancer Phase II 
PM00104 Zalypsis® Sea slug Cancer Phase II 
Tasidotin, 
Synthadotin (ILK-
651) 
NA Bacterium Cancer Phase II 
PM060184 NA Sponge Cancer Phase I 
Bryostatin 1 NA Bryozoa Cancer Phase I 
SGN-75 NA Sea hare Cancer Phase I 
Marizomib 
(Salinosporamide 
A, NPI-0052) 
NA Actinomycete Cancer Phase I 
 
In the last two decades, a significant number of new compounds with several 
chemical structural types have been discovered from marine organisms, for example 
alkaloids, polyketides, peptides, lipids, proteins and glycosides, some of which present 
interesting biological activities such as anticancer, antibacterial, antifungal, antioxidant and 
antifouling properties (Rateb and Ebel, 2011). Some of the marine microorganisms, such 
as fungi, bacteria, actinomycetes and cyanobacteria have become an important source of 
pharmacologically active metabolites in the search for novel compounds for drug discovery 
(Bugni and Ireland, 2004a; Saleem et al., 2007). Since microorganisms are renewable and 
reproducible sources, they can be cultured and can even be considered as a microbial 
factory for the natural products production (Blunt et al., 2015). Moreover, marine organisms 
have the potential to provide new therapeutic alternatives for treating human diseases 
(Galeano et al., 2011). These are the main reasons why marine natural products are being 
investigated very widely today. 
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1.3. Fungi as a Source of Bioactive Secondary Metabolites 
 
Although about 1.5 million species of fungi are believed to exist all over the world, 
only around 72,000 fungal species have already been described worldwide (Singh and 
Aneja, 2012). From these numerous species, fungi have been used as a source of drug for 
about 80 years. The discovery of penicillin from Penicillium notatum by Alexander Fleming 
had attracted more attention of many researchers to consider fungi as a source of novel 
drug leads. Several structurally diverse groups of compounds, including organic acids, 
polyynes, polyketides (such as quinones, anthraquinones and xanthones), monoterpenes 
to triterpenes (volatiles and steroids), polysaccharides, lipopolysaccharides and N-, S- 
containing compounds have been isolated from fungi (Gill and Steglich, 1987; Quang et al., 
2005; Steglich et al., 2000; Turner, 1971).  
 
About 20 years after the discovery of penicillin, fungi provided many active 
compounds for potential modern drugs, including the antihypercholesterolemic drugs 
statins, antifungal agents such as cyclosporine and echinocandin, and several antibiotics 
such as streptomycin, chloramphenicol, chlortetracycline, cephalosporin C and vancomycin 
(Butler, 2004; Larsen et al., 2005). Moreover, Butler (2004) reported that the fungal natural 
products can be used for other purposes, for examples cyclosporine is used as 
immunosuppressant during organ transplantation, while both natural compounds (such as 
lovastatin, pravastatin), and the synthetic analogs (such as crestor, lipitor) are used for 
treatment of cardiovascular and metabolic diseases. From 1995, the fungal-derived 
medicines are in the top twenty-selling prescription drugs in worldwide (Singh, 1999). 
 
In the last decades, marine fungi are well recognized as a source of novel and 
biologically active natural products for drug discovery (Duarte et al., 2012; Xu et al., 2015). 
Figure 3 shows that the number of new marine-derived fungal compounds which are 
published in each year is rapidly increasing, and still has not reached its climax. Currently, 
more than 1000 of new natural products from marine-derived fungi have been reported 
(Rateb and Ebel, 2011).  
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Figure 3. New compounds from marine-derived fungi, according to year of publication 
[Adapted from Rateb and Ebel (2011)]. 
 
 
1.3.1. Fungi and Marine Ecology 
 
 Marine fungi live in diverse marine environments such as oceanic, coastal, 
estuaries, deep-sea water and sediment habitats. Marine fungi are different from terrestrial 
and fresh water fungi in several ways. They can live in an extreme salinity of seawater, in 
average 33 to 35 ppt. They are able to adapt themselves to several factors such as 
increasing pH, high sodium levels, low temperature, low light and oligotrophic nutrient 
conditions in deep-sea environment with many challenges for survival (Jennings, 1983; 
Raghukumar, 2008). 
  
Marine fungi can be divided into obligate marine fungi and facultative marine fungi. 
The obligate marine fungi can grow and sporulate exclusively in the marine habitat, while 
the facultative marine fungi are generally found in terrestrial or freshwater habitats, but they 
also can live and sporulate in the marine environment. (Kohlmeyer and Kohlmeyer, 1979). 
There are 530 filamentous marine fungi species in 321 genera and most of them are in the 
order Ascomycota (424 species in 251 genera), followed by Deuteromyces (anamorphic 
fungi) with 94 species in 61 genera and Basidiomycota with 12 species in 9 genera (Jones 
et al., 2009).  
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Generally, marine fungi live as symbionts in marine organisms such as algae, 
mangrove plants, corals, sea anemone, starfish, seagrass, sea urchin and especially 
sponges (Jin et al., 2016). Different sources of marine-derived fungi seem to influence the 
number and nature of the fungal metabolites. Fungal secondary metabolites may act 
specifically in interspecies interactions to protect the host against competitor or diseases 
(Bugni and Ireland, 2004b). Rateb and Ebel (2011) gave an overview about the sources of 
new chemical structures from marine-derived fungi until mid-2010 (Figure 4). Figure 4 
shows that most of new compounds reported from marine fungi are derived from sponges 
and algae. 
 
 
Figure 4. Sources of new marine-derived fungi reported in literature until mid-2010 [ 
Adapted from Rateb and Ebel (2011)]. 
 
 
1.3.2. Sponge - Associated Fungi as a Source of Bioactive Compounds 
 
From 1985 to 2012, more than 15,000 chemical substances, including 4,196 
bioactive marine natural products were found. Approximately 75% of the novel bioactive 
compounds were derived from marine invertebrates, mainly from sponges (Phylum 
Porifera) and corals (Phylum Cnidaria). Sponges play an important role as the most 
productive source of new bioactive agents in preclinical development (Hu et al., 2015). 
Moreover, sponges are also well known to be the hosts for a large community of 
microorganisms, including fungi and bacteria.  
 
Microbes can compose up to 60% of the sponge tissue volume (Usher et al., 2004). 
From the microbe symbioses, sponges may benefit from the store of nutrients, 
transportation of waste products, chemical defense or contribution to mechanical structure 
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to avoid predation and combat pathogens and competitors (Kubanek et al., 2003; Unson et 
al., 1994; Wilkinson, 1978; Wilkinson and Garrone, 1980; Wilkinson et al., 1999). From 
these relationships, researchers have paid more attention to investigate marine sponges as 
a source of natural products. According to the review of Thomas et al. (2010), the major 
microorganisms which provide pharmacologically relevant secondary metabolites of 
sponges including fungi, cyanobacteria, actinobacteria, proteobacteria and firmicutes. 
However, accumulating evidence has lately showed that fungi associated with sponges are 
the origin of many interesting compounds (Proksch et al., 2008). Interestingly, Thomas et 
al. (2010) have found that more than 680 fungal strains isolated from 16 sponge species 
mainly belong to the filamentous fungi Penicillium and Aspergillus genera. 
 
Filamentous fungi are known to produce a wide variety of biologically active 
compounds and some of them are useful in drug development (Schueffler and Anke, 2014). 
Examples of bioactive compounds derived from sponge-associated fungi include IB-01212, 
a cytotoxic cyclodepsipeptide isolated from the sponge-associated fungus Clonostachys sp. 
ESNA-A009. This compound was found to be cytotoxic against 14 different human tumor 
cell lines, however it was most active against LN-caP (prostate cancer), SK-BR3 (breast 
cancer), HT29 (colon cancer) and HELA (cervix cancer) cell lines with  GI50 (growth 
inhibition) values in the order of 10-8 M (Cruz et al., 2006). Epoxyphomalin A, isolated from 
the fungus Phoma sp. which was isolated from the marine sponge Ectyplasia perox, 
exhibited a cytotoxicity at nanomolar concentrations against 12 human tumour cell lines, 
with IC50 values ranging from 0.010 μg/ml to 0.038 μg/ml (Mohamed et al., 2009). 
Similanamide, a new cyclohexapeptide, isolated from sponge-associated fungus 
Aspergillus similanensis KUFA 0013, exhibited a weak activity against three human cancer 
cell lines: breast adenocarcinoma (MCF-7), non-small cell lung cancer (NCI-H460) and 
melanoma (A373) (Prompanya et al., 2015). Hypofuran A, a new furan derivative, was 
isolated from a marine fungus Hypocrea koningii PF04 which was associated with the 
marine sponge Phakellia fusca. This compound exhibited a moderate antibacterial activity 
against Straphylococcus aureus ATCC25923 (MIC 32 μg/mL) and moderate DPPH radical 
scavenging capacity with IC50 values of 27.4 μg/mL (Ding et al., 2015b). Another example 
is austalide R, a new meroterpenoid from the fungus Aspergillus sp. which was isolated 
from the marine sponge Tethya aurantium, showed the antibacterial activity against a panel 
of marine bacteria (Zhou et al., 2014). The examples of the compounds derived from 
filamentous fungi demonstrated that they are important sources of bioactive secondary 
metabolites.  
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One of the bioactive compound-producing genera of the filamentous fungi is 
Talaromyces. Several members of this genus have been investigated for their bioactive 
secondary metabolites (Nicoletti and Trincone, 2016; Zhai et al., 2016). Therefore, marine-
derived members of this genus are targets of the investigation of our group.  
 
 
 
Figure 5. Structures of IB-01212, epoxyphomalin A, similanamide, hypofuran A and 
austalide R. 
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1.4. The Genus Talaromyces 
 
 The genus Talaromyces belongs to the family Trichocomaceae. The name 
Talaromyces is derived from the Greek word for ‘basket’, describing the shape of the 
ascospores which characterizes the morphology of the fungi in this genus (Zhai et al., 2016). 
In 1995, the American mycologist Chester Ray Benjamin introduced the genus Talaromyces 
as asexual stage of Penicillium that produces soft walled ascomata covered with interwoven 
hyphae, globose and ovate asci which are produced in chains containing the spiny 
ascospores and showing yellowish or reddish ornamentations (Benjamin, 1955; Stolk and 
Samson, 1972). In 2000, 46 species and 6 varieties of the genus Talaromyces were found 
in soil, manure, dung, rubble, foods, industrial and agricultural wastes with worldwide 
distribution (Pitt et al., 2000).  
 
 
1.4.1. Taxonomy 
 
Stolk and Samson (1972) classified Talaromyces into 4 sections, including section 
Talaromyces, Emersonii, Thermophila and Purpurea, which are primarily based on the 
morphological characteristics of their anamorph states (Stolk and Samson, 1972); 
 
 
Figure 6. Talaromyces Taxonomy. 
 
1.4.1.1. Section Talaromyces 
 
The conidial state belongs to the Penicillium of the biverticillate - symmetrical type. 
They present yellow ascocarp with yellow ascospores, in some strains produce plentiful of 
red pigment. This section contains 10 species, 2 varieties: Talaromyces rotundus, T. luteus, 
T. udagawae, T. stipitatus, T. ucrainicus, T. flavus, T. macrosporus, T. wortmannii, T. 
trachyspermus, T. intermedius, T. helicus var. helicus and T. helicus var. major. The species 
belonging to this section are mesophilic with 25°C of optimum temperature and 40°C of 
maximum temperature. There are various types of initial ascomata, paired gametangia in 3 
species; T. flaves, T. helicus and T. stipitatus, while in others develop as branches of 
hyphae. This section usually produces 8-spored asci in short coiled chains. Ascospores are 
normally cylindrical with their walls presenting various ornamentations.  
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Figure 7. Morphology of Penicillium of the biverticillate - symmetrical type (T. wortmannii; 
a. conidiogenous structures; b. conidia; c. initials; d. chains of asci; e. ascospores) [Adapted 
from Stolk and Samson (1972)]. 
 
1.4.1.2. Section Emersonii 
 
The anamorph state belongs to the Penicillium cylindrosporum – series or 
Paecilomyces. They have yellow ascospores and distinctly deficient the covering of 
ascocarp. This section consists of 4 species: Talaromyces byssochlamydoides, T. 
bacillisporus, T. emersonii and T. leycettanus. They are thermophilic with 35-45°C optimum 
temperature. No paired gametangia occur in all four species. They are short, curved asci 
with 8-spored. Ascospores are globose and have smooth walls. 
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Figure 8. Morphology of Penicillium cylindrosporum (T. byssochlamydoides; a. 
conidiogenous structures; b. conidia; c. initials; d. chains of asci; e. ascospores; f. loose-
textured hyphae covering the ascoma) [Adapted from Stolk and Samson (1972)]. 
 
1.4.1.3. Section Thermophila 
 
The imperfect state is classified in the Penicillium asymmetrica - Divaricata, near the 
P. janthinellum - series. Ascospores are produced in branched chains and the ascocarps 
are well-developed walls (thick walls). There is only one species in this section: 
Talaromyces thermophilus. The section Thermophila differ from other sections because 
they are strongly thermophilic, which are able to produce ascomata at 45°C (rarely produce 
on agar media), and asci are produced in straight and branched chains while others of the 
genus Talaromyces are produced in helicoidal chains.  
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Figure 9. Morphology of Penicillium asymmetrica - Divaricata (T. thermophilus; a. 
conidiogenous structures; b. conidia; c. initials; d. primordium consisting of branching 
hyphae; e. chains of asci; f. ascospores; g. fragment of ascomatal covering; h. 
chlamydospores; i. vegetative hyphae) [Adapted from Stolk and Samson (1972)]. 
 
1.4.1.4 Section Purpurea 
 
The anamorph state is Penicillium restrictum - series. They have thin, loose-textured 
network of hyphae and yellow ascomata (ascocarps). Ascospores are yellow and red. This 
section contains only one species: Talaromyces purpureus. 
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Figure 10. Morphology of Penicillium restrictum - series (T. purpureus; a. conidiogenous 
structures; b. conidia; c. initial surrounded by thin hyphae; d. initials; e. chains of asci; f. 
ascospores; g. loosely branched hyphae covering the ascoma) [Adapted from Stolk and 
Samson (1972)]. 
 
 
1.4.2. The Importance of Talaromyces 
 
Fungi belonging to the genus Talaromyces are very important for human life in 
several ways. They provide not only various pigments which are used as natural dyes but 
also the compounds useful in agricultural and biotechnological applications. On the other 
hand, some species can cause many fatal diseases in human life and deleterious effects in 
food industry due to the heat resistance of their ascospores and contamination of mycotoxin 
in the food products (Frisvad and Filtenborg, 1988).  
 
1.4.2.1. Importance in Agricultural Applications 
 
 The genus Talaromyces is a ubiquitous and important fungal genus. The members 
of this genus were isolated from soil, plants, foods and sponges. One of the most important 
fungi that was used as a bio-control agent in agriculture is Talaromyces flavus which is an 
antagonistic fungus against soil-borne pathogens such as Verticillium dahliae, Verticillium 
albo-atrum, Rhizoctonia solani and Sclerotinia sclerotiorum (Boosalis, 1956; Marois et al., 
1984; McLaren et al., 1986; Naraghi et al., 2010). For example, T. flavus can suppress and 
control the Verticillium wilt of greenhouse cucumber (Naraghi et al., 2011), V. albo-atrum 
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wilt of tomato and potato (Naraghi et al., 2010), V. dahliae  wilt of cotton (Naraghi et al., 
2006), Verticillium wilt of eggplant (Marois et al., 1982), white mold (Sclerotinia sclerotiorum) 
of dry bean (Huang et al., 2000) and also against Rhizoctonia solani of sugar beet seedling 
damping-off disease (Kakvan et al., 2013). Moreover, T. flavus can stimulate the growth of 
cotton and potato (Naraghi et al., 2012). The mechanisms for bio-control activity include 
competition, mycoparasitism and antibiosis (Adams, 1990; Madi et al., 1997; Marois et al., 
1984; Stosz et al., 1996). In contrast, some species can cause disease in plants, for 
example T. islandicus causes yellowing of rice in Japan (Sakai et al., 2005).  
 
	 1.4.2.2. Importance in Biotechnological Applications 
 
	 	 1.4.2.2.1. Biomass Degradation 
 
  Many species of the genus Talaromyces are used for biotechnological 
purposes because of their ability to produce soluble enzymes. There are many important 
enzyme producer species such as T. rugulosus which produces b-rutinosidase and 
phosphatase (Narikawa et al., 2000; Reyes et al., 1999), T. wortmannii (T. variabilis) which 
produces urethanase (Gu and Tian, 2013) and T. pinophilus (=T. cellulolyticus) which is 
used as an important cellulose-degrading enzyme producer in biomass degradation (Fujii 
et al., 2014; Pol et al., 2012).  
 
	 	 1.4.2.2.2. Food Industry 
 
 
Figure 11. Pigments from filamentous fungi in food industry; A. Pigmented filamentous 
fungi; B. Pigments and colorants produced and extracted and C. Food formulation and 
processing [Adapted from Dufosse et al. (2014)].  
 
Filamentous fungi are being investigated as a natural source of food 
colorants. Normally, members of the genus Talaromyces produce yellow, orange and 
purple-red pigments. More than centuries, Monascus has traditionally been used as natural 
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food colorants and food preservative of meat and fish in Asia (Lin et al., 2008). T. aculeatus, 
T. funiculosus, T. purpurogenus and T. pinophilus have been reported to produce 
Monascus-like polyketide azaphilone (MPA) pigments without co-production of mycotoxin 
citrinin (Mapari et al., 2008). Also, T. amestolkiae, T. stollii and T. ruber have been 
discovered to produce this red pigments (Yilmaz et al., 2012). 
 
 
Figure 12. Screening for filamentous fungi producing pigments of interest without any co-
production of mycotoxins and Monascus-like pigment produced by Penicillium [Adapted 
from Dufosse et al. (2014)].  
 
T. atroroseus is the optimal producer of important yellow and red pigments 
for industrially colorants. It can produce not only the yellow pigments such as monascin, 
monascurubrin, xanthomonascin A and another series of yellow mitrorubrin azaphilones but 
also several red pigments (Frisvad et al., 2013).  
 
  One of the main problems in food industry are spoilage and poisoning of food 
products caused by fungi (Pitt and Hocking, 2009). Some members of Talaromyces are 
very important in food industry because of their heat resistant ascospores which can cause 
spoilage in pasteurized food products. Many species that produce heat resistant 
ascospores have been reported. T. trachyspermus, T. flavus, T. stipitatus, T. bacillisporus, 
T. wortmannii and T. helicus, isolated from commercial fruit juices, caused spoilage in fruit 
products (Dijksterhuis, 2007; Enigl et al., 1993; Pitt and Hocking, 2009; Scott and Bernard, 
1987). T. macrosporus can occur in pasteurized foods (Frisvad and Filtenborg, 1988). 
 
Mycotoxins can contaminate in a wide range of food including meats, fruits, 
cheeses, spices and wines. It showed acute and chronic toxicity at low concentrations and 
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some are mutagenic or carcinogenic causing hepatic cancer in human (Aziz et al., 2006; 
Petzinger and Weidenbach, 2002). Some species of the genus Talaromyces can cause 
mycotoxin contamination in food products. Talaromyces purpurogenus produced four 
different kinds of mycotoxins: rubratoxins, luteoskyrin, spiculisporic acid and rugulovasins 
(Yilmaz et al., 2012). In 1996, rubratoxin was reported to cause the critical illness, requiring 
immediate liver transplant in the three teenagers after drinking rhubarb wine, which 
contained high level of rubratoxins (Sigler et al., 1996). Interestingly, rubratoxins were 
showed to exhibit anticancer activity (Wada et al., 2010). Talaromyces islandicus is a 
harmful storage fungi which caused “yellow rice syndrome”. The japanese government 
started foodstuff controlling for safety because this fungus produces two hepatotoxic 
metabolites: luteoskyrin and cyclochlorotine (Udagawa and Tatsuno, 2003). Moreover, T. 
islandicus can produce numerous industrially important extracellular enzymes such as 
cellulases, chitosanases, proteases, b-galactofuranosidase and polygalacturonases 
(Schafhauser et al., 2015). Moreover, some species are beneficial for food and beverage 
productions such as Oak chips inoculated with T. purpurogenum are used for artificial aging 
of red wines as an alternative to wood barrel aging (Petruzzi et al., 2012). 
 
1.4.2.3. Importance in Medical Applications 
 
Talaromyces was reported to be medically important in several publications since 
this genus contains species that cause many fatal diseases for human. For example, T. 
marneffei is the third most common opportunistic infection in patients with the acquired 
immunodeficiency syndrome (AIDS). This fungal infection is frequently found in Southeast 
Asian countries, China and Hong Kong (Supparatpinyo et al., 1998). In 2010, T. indigoticus 
was isolated from human skin and nail lesions which were affected by onychomycosis in 
Panama and the American continent (Weisenborn et al., 2010). T. piceus causes 
inflammation of rib bone or bone marrow in an X-linked chronic granulomatous disease (X-
CGD) and fungal infection in blood (Horré et al., 2001; Santos et al., 2006). T. amestolkiae 
was isolated from sputum and lungs of cystic fibrosis patients (Yilmaz et al., 2016). In the 
previous studies, T. purpurogenus was found to cause the human lungs infection in the 66-
year-old woman patient with multiple myeloma (Atalay et al., 2016). However, fungi of this 
genus are found to produce several bioactive secondary metabolites which can be 
considered useful in drug discovery. For example, talaperoxides B and D, isolated from the 
mangrove-derived fungus Talaromyces flavus, are cytotoxic against several human tumor 
cell lines such as HeLa, HepG2, MCF-7, PC-3 and MDA-MB-435 with IC50 = 2.8-9.4 μM (Li 
et al., 2011). Moreover, the marine fungus Talaromyces sp. Strain LF458 produced 
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acetylcholinesterase inhibitors, namely talaromycesones A, B and AS-186c which 
showed potent acetylcholinesterase inhibitory activity with IC50 7.49, 1.61 and 2.60 μM, 
respectively (Wu et al., 2015). 
 
 
1.5. Obesity 
 
 Obesity is becoming a major public worldwide health problem with inestimable social 
costs. The World Health Organization (WHO) reported that about 39% of adult (≥ 20 years 
old) world’s population were overweight in 2014. The international consortium of 
researchers of the Institute for Health Metrics and Evaluation (IHME) at the University of 
Washington also stated that the global overweight (BMI range: 25-30 kg/m2) and obesity 
(BMI range: > 30 kg/m2) rates were increased in the last three decades presenting a health 
problem in both the developing and the developed countries. During 1980-2013, the rates 
of obesity among adults have increased for both men (from 29% to 37%) and women (from 
30% to 38%) (Ng et al., 2014).  
 
Obesity has effects not only on personal quality of life, but numerous diseases and 
mortality also. It causes many diseases, including diabetes, hypertension, osteoarthritis and 
heart diseases. In the present, there are only two most prescribed anti-obesity drugs in 
global pharmaceutical market: orlistat and phentermine. Both drugs have adverse effects 
such as dry mouth, headache, insomnia, increased blood pressure and constipation. There 
is still a lack of efficient and safe drugs for curing obesity. For this reason, a wide variety of 
natural products have been studied for this aspect (Castro et al., 2016; Yun, 2010). 
 
Terrestrial and aquatic organisms were explored for their anti-obesity bioactive 
compounds. Some of them have been used in traditional medicines for centuries. Many 
extracts and secondary metabolites derived from plants such as extracts from Panax 
japonicas, roots of Platycodi redix, Nelumbo nucifera and Salix matsudana have been 
reported for their pancreatic lipase inhibitory activity. The phytochemicals include saponins, 
polyphenols, caffeine and flavonoids. Although many phenolic compound-containing plant 
extracts such as flavonoids have been demonstrated to have potential as anti-obesity 
agents, only few anthraquinones have been investigated for their anti-obesity potential 
(Choudhary, 2011; Yun, 2010). Tzeng et al. (2012) have found that the anthraquinone 
emodin has anti-obesity and antihyperlipidaemic effects which caused dose related 
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reductions in the hepatic triglyceride and cholesterol contents and lowered hepatic lipid 
droplets accumulation in high-fat diet-fed rats. 
 
Microorganisms and marine algae have been also screened for anti-obesity 
property. However, only few of them have been explored and studied (Table 2). 
 
Table 2. Anti-obesity compounds from microorganisms and algae (Yun, 2010). 
 
 
The screening of potent molecule on their anti-obesity activity has been studied in 
several cell lines such as murine 3T3-L1 adipocytes (Roh and Jung, 2012), 3T3-F442A 
preadipocytes, OP9 stromal adipocytes, porcine primary preadipocytes and feline primary 
preadipocytes (Choudhary, 2011; Ruiz-Ojeda et al., 2016). However, the in vitro assays 
have limitations in adipogenic differentiation time, the difficulty in transfection of cells and 
lack of the information about the physiological conditions and complex interactions among 
different type of cells and tissues (Ruiz-Ojeda et al., 2016). 
 
Animal models can provide the fundamental parameters that regulate the 
physiological and genetic basis of obesity (Speakman et al., 2008). Several animal models 
(commonly rodents) are used for the discovery of various treatments for obesity and for the 
study of factors causing obesity. Nevertheless, rat and mice have limitation about the 
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missing of leptin protein, which is a key part of body’s system of weight regulation, or the 
body temperature regulating receptor problem, their low speed and high cost of animal 
model (Vogel, 2000). Therefore, the small size animal models have been developed 
including vertebrates (zebrafish), invertebrates (the nematode; Caenorhabditis elegans 
(Link et al., 2000), and the fruit fly; Drosophila melanogaster (Shulman et al., 2003)) for drug 
screening. 
 
 Since it is a vertebrate, the zebrafish is genetically closer to human than worms and 
flies. The zebrafish is accepted as the simplest animal model with full complement of 
vertebrate organs and their transparency bodies that can be used in the screening of the 
gene regulating lipid metabolism. The advantages of zebrafish are they are small whole 
animal model with quick generation time, low cost, amenable with large-scale screening 
and higher physiological relevance over cellular in vitro models for bioactive compound 
screening (Giacomotto and Ségalat, 2010; Vogel, 2000). Moreover, the zebra larvae Nile 
red assay is suitable to detect anti-obesogenic activities, and it exhibited similarly response 
to human in screening the lipid regulator drugs (Jones et al., 2008). Nowadays, the potential 
of natural products which can be used in the treatment of obesity is still largely unexplored, 
especially microorganism sources. The active exploration and testing of new metabolites 
for anti-obesity activity may provide the hope for new drug developments. 
 
 
1.6. Objectives 
 
 The main goal of this dissertation consists of two parts: i) to isolate, purify and 
elucidate the structure of the secondary metabolites from the sponge-associated fungus 
Talaromyces stipitatus (KUFA 0207), which was isolated from the marine sponge Stylissa 
flabelliformis, collected from the Gulf of Thailand (Samaesan Island), Chonburi province, 
Thailand, ii) to evaluate the bioactivities of the isolated secondary metabolites. 
 
 
 
		
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
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2. Secondary Metabolites from the Fungi of the Genus 
Talaromyces Section Talaromyces and Their Bioactivities 
 
The genus Talaromyces generates a wide range of compounds (used as natural 
colorants) and soluble enzymes that are useful in biotechnological applications. However, 
some species are also used as bio-control agents in agriculture, whereas other members 
are human pathogens. Some species can cause fatal diseases in human while others cause 
spoilage and poisoning in food products due to their heat-resistant ascospores. Considering 
their importance, this genus is widely investigated including their bioactive secondary 
metabolites. 
 
Stolk and Samson (1972), have divided Talaromyces into 4 sections: Talaromyces, 
Emersonii, Thermophila and Purpurea. In this study, we focused on Talaromyces stipitatus 
which belongs to the section Talaromyces. The morphological characteristic of this fungus 
was showed in Figure 13. We considered secondary metabolites of the species in the 
section Talaromyces which comprise of Talaromyces rotundus, T. luteus, T. udagawae, T. 
stipitatus, T. ucrainicus, T. flavus, T. macrosporus, T. wortmannii, T. trachyspermus, T. 
intermedius, T. helicus var. helicus and T. helicus var. major (Stolk and Samson, 1972). 
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Figure 13. Morphological characteristics of Talaromyces stipitatus (CBS 236.60); A. 
Colonies from left to right (top row) CYA, MEA, DG18 and OA; (bottom row) CYA reverse, 
MEA reverse, YES and CREA; B. Colony texture and ascomata on OA after 2 weeks’ 
incubation; C. Ascomata; D, E. Asci and ascospores; F. Ascospores. Scale bars: 
B = 1000 μm; C = 500 μm; D = 10 μm, applies to E, F. (Yilmaz et al., 2014).  
 
 Zhai et al. (2016) reported that 221 secondary metabolites, including alkaloids, 
peptides, esters, polyketides, quinones, steroids, terpenoids and other structural type 
compounds, were isolated from the species of the genus Talaromyces. However, in this 
		
	
26	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
study, only 110 compounds and their bioactivities from only six species in the section 
Talaromyces of genus Talaromyces are presented below. 
 
 
2.1. Talaromyces flavus 
 
 Since T. flavus was used as a bio-control agent against soil-borne pathogens in 
agricultural application and has an ability to produce heat resistance ascospores, numerous 
secondary metabolites of diverse structural types such as esters, polyketides, quinones, 
steroids and terpenoids, among others, were isolated from this fungus. He et al. (2014b) 
reported the isolation and their bioactivities of the secondary metabolites, including six 
polyesters, talapolyesters A-F (1-4, 14 and 16) along with eleven macrolide polyesters, 
15G256v (5), 15G256v-me (6), 15G256P (7), 15G256b-2 (8), 15G256a-2 (9), 15G256a-2-
me (10), 15G256i (11), 15G256b (12), 15G256a (13), 15G256a-1 (15) and 15G256w (17), 
from the wetland soil-derived fungus T. flavus BYD07-13. While compounds 12, 13 and 15 
showed toxicity against mouse peritoneal macrophage, the macrocyclic polyesters 11-17 
displayed cytotoxicity against five tumor cell lines: HL-60, SMMC-7721, A-549, MCF-7 and 
SW480. Interestingly, the cyclic compounds 12 and 17 exhibited significant cytotoxicity 
against MCF-7 cell line with IC50 value of 3.27 and 4.32 μM, respectively, while the linear 
polyesters 1-10 were inactive (IC50>40 μM) (He et al., 2014b)  
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Figure 14. Secondary metabolites of Talaromyces flavus (1-16). 
		
	
28	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
 
Figure 15. Structure of 15G256w (17). 
 
 In 1990, a coumarin (18), two isocoumarin derivatives (21 and 22) and phthalide 
derivative (23) were isolated from the organic extracts of soil fungus T. flavus (Ayer and 
Racok, 1990). Later, He et al. (2014c) isolated two new coumarins, talacoumarins A (19) 
and B (20) from the ethyl acetate extract of the wetland soil-derived fungus T. flavus BYD07-
13. The two compounds had moderate anti-Ab42 aggregation activity. Vermistatin (24) was 
obtained from the culture broth of T. flavus FKI-0076 as well as from the extract of T. flavus 
IFM52668 (Arai et al., 2002).  
 
 
Figure 16. Secondary metabolites of Talaromyces flavus (18-24). 
 
Ayer and Racok (1990) isolated many secondary metabolites from the organic 
extracts of this fungus, including a lactone (25), D-glucono-1,4-lactone (26), 
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hydroxymethylmaltol (27) and a benzopyrone derivative (28). Funicone (29) and funicone-
related compounds i.e. 9,14-epoxy-11-deoxyfunicone (30), deoxyfunicone (31) and 
actofunicone (32), were also obtained from the strain of T. flavus. Funicone (29) showed 
antifungal activity against a human pathogenic filamentous fungus Aspergillus fumigatus 
(11-mm inhibition zone at 100 μg/disc), while compound 30 exhibited weak inhibition against 
A. niger (10-mm inhibition zone at 200 μg/disc) (Arai et al., 2002; Nicoletti et al., 2009). 
 
 
Figure 17. Structures of the secondary metabolites 25-32, isolated from Talaromyces 
flavus. 
 
 Diazaphilonic acid (33), isolated from T. flavus PF1195, inhibited DNA amplification 
by polymerase chain reaction (PCR) with Thermus thermophilus DNA polymerase, with the 
IC50 value of 2.6 μg/mL, and almost completely inhibited telomerase activity of human 
leukemia at 50 μM (Tabata et al., 1999). 
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Figure 18. Structure of diazaphilonic acid (33). 
 
 Moreover, T. flavus can produce several terpenoid structural types. A novel 
nardosinane sesquiterpene, talaflavuterpenoid A (34), isolated from the wetland soil-
derived fungus T. flavus BYD07-13, exhibited cytotoxic activity against five human cancer 
cell lines: HL-60, SMMC-7721, A-549, MCF-7 and SW480, with IC50 > 40 μM as well as 
antimicrobial activities against Escherichia coli, Staphylococcus aureus, Candida albicans, 
and Aspergillus niger (MIC > 1.0 mg/mL) (He et al., 2014a). Four norsesquiterpene 
peroxides, talaperoxides A-D (35-38) and steperoxide B (39) were isolated from a mangrove 
endophytic fungus T. flavus. Talaperoxide B (36) and steperoxide B (39) showed 
cytotoxicity against five human tumor cell lines: MCF-7, MDA-MB-435, HepG2, HeLa and 
PC-3, with IC50 values between 0.70 and 2.78 μg/mL (Li et al., 2011). 
 
 
Figure 19. Structure of compounds 34-39. 
O
O
O
O
O
O
O
O
O
O
HO
OH
COOH
COOH
OH
HO 33
O
O
O
O
OR
O
O
O
O
OAc
O
O
O
O
O
O
O
O
34
35 R=Ac
39 R=H 36
37 38
		
	
31	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
 A benzoic acid derivative (40), altenusin (41), 5-hydroxymethylfurfural (42) and 
fosfonochlorin (43) were isolated from the fungus T. flavus. Altenusin (41) showed an ability 
to inhibit the enzyme HIV-1 integrase in the coupled and the strand-transfer assays with 
IC50 values of 19 μM and 25 μM, respectively. Compound 43 was active against Proteus 
vulgaris and P. mirabilis and weakly active against Klebsiella pneumoniae, Providencia 
rettgeri and Salmonella enteritidis (Ayer and Racok, 1990; Singh et al., 2003; Takeuchi et 
al., 1989). 
 
 
Figure 20. Structures of compounds 40-43. 
 
 
2.2. Talaromyces helicus 
 
 Osmanova et al. (2010) reported an isolation of four chlorinated azaphilones, 
helicusins A (44), B (45), C (46) and D (47) from T. helicus. Helicusins A-D presented weak 
MAO-inhibitory activity. 
 
 
Figure 21. Structures of helicusins A-D (44-47). 
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2.3. Talaromyces luteus 
 
Two monoamine oxidase (MAO) inhibitors, luteusins A (48) and B (49) were isolated 
from T. luteus (Fujimoto et al., 1990). Later on, Yoshida et al. (1996) discovered luteusins 
C (50), D (51) and E (52) from this fungus but the three compounds had no MAO-inhibitory 
activity. 
 
 
Figure 22. Structures of luteusins A-E (48-52). 
 
 
2.4. Talaromyces stipitatus 
 
 Zang et al. (2015) isolated and characterized four new compounds: talaroenamines 
B-E (54-57) along with the previously reported talaroenamine A (53) and a new linear 
polyester, talapolyester G (58) from the fungus T. stipitatus ATCC 10500. Talaroenamine D 
(56) exhibited inhibition against the chloroquine-resistant Plasmodium falciparum, however, 
it showed no toxicity on HeLa and preadipose cell lines. Frisvad et al. (1990) reported the 
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isolation of emodin (59), catenarin (60), duclauxin (61), erythroglaucin (62) and stipitatic 
acid (63) from this fungus.  
 
 
Figure 23. Structures of compounds 53-63. 
 
 Two novel oxaphenalenone dimers, talaroketals A (64) and B (65) were isolated 
from the soil fungus T. stipitatus. These two compounds present moderately antimicrobial 
activity against Staphylococcus aureus (Zang et al., 2016). 
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Figure 24. Structures of talaroketals A (64) and B (65). 
 
 Phillips et al. (1987) discovered four new spiroketal talaromycins, talaromycins C 
(68), D (69), E (70) and F (71) from T. stipitatus. This fungus produces mycotoxins such as 
duclauxin (61), botryodiplodin (72) and talaromycins A (66) and B (67) (Hashimoto et al., 
2015; Lynn et al., 1982). Moulé et al. (1981) reported the inhibition of cell multiplication in 
growing cultures of mammal cells by botryodiplodin (72) without any toxic effect. 
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Figure 25. Structures of talaromycins A-F (66-71) and botryodiplodin (72). 
 
 
2.5. Talaromyces trachyspermus 
 
 Frisvad et al. (1990) have identified the presence of spiculisporic acid (73) from the 
culture of Talaromyces trachyspermus, and later on, Kuml et al. (2014) isolated a new 
analog of spiculisporic acid, spiculisporic acid E (74) in addition to 3-acetyl ergosterol 5,8-
endoperoxide (75) from the culture of the marine-sponge associated fungus T. 
trachyspermus (KUFA 0021). Trachyspic acid (76) was isolated from the culture broth of T. 
trachyspermus (SANK 12191). Compound 76 is also a new metabolite which inhibited the 
enzyme heparanase with IC50 value 36 μM (Shiozawa et al., 1995). 
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Figure 26. Structures of spiculisporic acid (73), spiculisporic acid E (74), 3-acetyl ergosterol 
5,8-endoperoxide (75) and trachyspic acid (76). 
 
 
2.6. Talaromyces wortmannii 
 
 The secondary metabolites from Talaromyces wortmannii comprised of diverse 
structural type compounds, including peptides, esters, polyketides, steroids and quinones. 
Two new cyclic peptides, talaromins A (77) and B (78) were isolated from the endophytic 
fungus T. wortmannii which derived from Aloe vera. Both cyclopeptides (77 and 78) showed 
neither cytotoxicity against L5178Y mouse lymphoma cells using the MTT assay nor 
antibacterial activity against a broad spectrum of bacterial strains up to a concentration at 
64 μg/mL (Bara et al., 2013b). A macrolide lactone antibiotic, namely, vermiculine (79) had 
been found in a crystalline form in agar and liquid media cultures of T. wortmannii by Jones 
et al. (1984). The fungus T. wortmannii, isolated from a soil sample collected in China’s 
Yunnan province, furnished four novel macrolides, wortmannilactones A-D (80-83). These 
compounds exhibited in vitro cytotoxicity against several human cancer cell lines with IC50 
values from 28.7 to 130.5 μM (Dong et al., 2006). 
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Figure 27. Structure of compounds 77-83. 
 
Another four new lactones, wortmannilactones E-H (84-87), were isolated from the 
culture of the soil filamentous fungus T. wortmannii. These compounds exhibited inhibitory 
activity against cathepsin B with IC50 values of 4.3, 6.5, 13.0 and 6.0 μM, respectively (Dong 
et al., 2009). 
 
 
Figure 28. Structures of wortmannilactones E-H (84-87). 
 
 Ding et al. (2015a) reported isolation of secovironolide (88), wortmannin (89), 11-
desacetoxywortmannin-17b-ol (90), 11-desacetoxywortmannin (91), wortmannolone (92), 
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epoxyvirone (93), wortmannin B (94), 3-dihydrovirone (95), wortmannin-diol (96), wortmin 
(97) and deacetylisowortmin (98) from the culture broth of endophytic fungus T. wortmannii 
LGT-4, which was isolated from the Chinese medicinal plant Tripterygium wilfordii. 
However, only compound 88 and 89 showed weak MAO inhibition with IC50 of 91.22 and 
40.17 μg/mL, respectively (Bara et al., 2013a; Ding et al., 2015a). 
 
 
 
Figure 29. Structures of compounds 88-98. 
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 Talaromyces wortmannii which was obtained from a healthy tissue of Aloe vera 
collected in Alexandria, Egypt, provides a number of quinone pigments such as biemodin 
(99), emodic acid (100), skyrin (101), oxyskyrin (102), rugulosins A (103) and B (104). Skyrin 
(101) and rugulosin A (103) exhibited antibiotic activity against Gram positive pathogenic 
bacteria, especially against Methicillin-resistant Staphylococcus aureus (MRSA) with MIC 
values between 4 and 6 μg/mL. Biemodin (99) also showed strong antibiotic activity against 
Gram positive bacteria but less than skyrin (101) and rugulosin A (103) (Bara et al., 2013a). 
 
 
Figure 30. Structures of biemodin (99), emodic acid (100), skyrin (101), oxyskyrin (102), 
regulosin A (103) and B (104). 
 
 Two bisdihydroanthracenone atropodiastereomeric pairs: homodimeric 
flavomannins A (105) and B (106), two unsymmetrical dimers 107 and 108, and two mixed 
dihydroanthraquinone dimers 109 and 110 were isolated from the endophytic fungus T. 
wortmannii. All the compounds showed antibacterial activity against Staphylococcus 
aureus, including (multi) drug-resistant clinical isolates, however they did not exhibit any 
cytotoxic activity (Bara et al., 2013c). 
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Figure 31. Structures of bisdihydroanthraquinones 105-110. 
 
 A recent review by Zhai et al. (2016) showed that diverse types of compounds, 
including polyester, macrolide, benzopyrone, terpenoid, amine, anthraquinone, peptide, 
steroid, azaphilone, oxaphenalenone, spiroketal and others were isolated from the fungi of 
the genus Talaromyces section Talaromyces. Interestingly, the most common bioactivities 
of the secondary metabolites of these fungi are cytotoxic and antibacterial activities as 
showed in Table 3. 
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Table 3. Summary of the structural types of the secondary metabolites and their biological 
activities from the genus Talaromyces section Talaromyces. 
 
 
 
Al: immunotherapy for Alzheimer’s disease; B: antibacterial activity; C: cytotoxic activity; F: 
antifungal activity; HIV: HIV-1 integrase inhibition; M: antimalarial; P: monoamine oxidase 
inhibition (treatment of Parkinson’s disease) and numbers in the parenthesis: represent 
numbers of the compounds described in chapter 2. 
 
 
 
		
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 
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3. Materials and Methods 
 
3.1. Materials 
 
3.1.1. Isolation and Purification of Secondary Metabolites from the 
Fungal Crude Extracts 
 
- Distilled water 
- Erlenmeyer flask size 250, 500, 1,000 mL. 
- Separating funnel 
- Filtrate pump 
- Paper filtrate Whatman No. 1 
- Laboratory mortar and pestle 
- Microcapillary pipettes, calibrated size 10 µL. 
- TLC aluminium sheets 20 x 20 cm silica gel 60 GF254, Merck 
- Silica gel 60 GF254 (0.2-0.5 mm), Merck for column chromatography 
- Silica gel 60 GF254, Merck for thin layer chromatography 
- Sephadex LH-20 for column chromatography 
- 20 x 20 glass plates 
- Tank chamber 
- Sea sand 
- Cotton 
- Vials, 4 drams 
- Hot plate 
- UV detector (254 nm and 365 nm) 
- Column chromatography 
- Rotary evaporator (Buchi) 
- Petroleum ether (Petrol) 
- Chloroform (CHCl3) 
- Acetone (Me2CO) 
- Methanol (CH3OH) 
- Ethyl acetate (EtOAc) 
- Formic acid (HCO2H) 
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3.1.2. Structure Elucidation of Secondary Metabolites 
 
- Proton Nuclear Magnetic Resonance (1H NMR) 
- Carbon-13 Nuclear Magnetic Resonance (13C NMR) 
- Heteronuclear Single Quantum Coherence (HSQC) 
- Correlation Spectroscopy (COSY) 
- Heteronuclear Multiple Bond Correlation (HMBC) 
- High Resolution Mass Spectrometry (HRMS) 
- Bock monoscope 
- ADP410 Polarimeter 
- FTIR spectrometer Nocolet iS10 
- Varian CARY 100 spectrophotometer 
- Bruker AMC instrument 
- Waters Xevo QToF mass spectrometer 
- Waters Aquity UPLC system 
 
 
3.2. Methods 
 
3.2.1. General Experimental Procedures 
 
 A Merck (Darmstadt, Germany) silica GF254 was used for preparative TLC, a Merck 
Si gel 60 (0.2-0.5 mm), LiChroPrep Si 60 (0.04-0.063) and Sephadex LH-20 were used for 
column chromatography. 
1H and 13C NMR spectra were taken in CDCl3 or DMSO-d6 and were recorded at 
ambient temperature on a Bruker AMC instrument (Bruker Biosciences Corporation, 
Billerica, MA, USA) operating at 300.13 and 75.4 MHz or 500.13 and 125.4 MHz, 
respectively. 
The solvents were evaporated at reduced pressure, using Büchi heating bath B-49, 
rotavapor R-210, vacuum module V-801 EasyVac and vacuum pump V-700. 
High resolution mass spectra were measured with a Waters Xevo QToF mass 
spectrometer (Waters Corporations, Milford, MA, USA) coupled to a Waters Aquity UPLC 
system.  
Optical rotations were measured on a ADP410 Polarimeter (Bellingham + Stanley 
Ltd., Tunbridge Wells, Kent, UK). 
Melting points were determined on a Bock monoscope and are uncorrected.  
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Infrared spectra were recorded in a KBr microplate in a FTIR spectrometer Nicolet 
iS10 from Thermo Scientific (Waltham, MA, USA) with Smart OMNI-Transmission 
accessory (Software 188 OMNIC 8.3).  
 
 
Figure 32. Equipment in the experimental, A. Bock monoscope; B. ADP410 Polarimeter; 
C. FTIR spectrometer; D. Bruker AMC instrument; E. Varian CARY 100 spectrophotometer; 
F. Waters Aquity UPLC system; G. Waters Xevo QToF mass spectrometer. [Adapted from 
http://www.selectscience.net/products/alpha-ftir-spectrometer/?prodID=80550; 
http://www.labequip.com/cary-100-cone-series-ii-uvvisible-scanning-spectrophotometer.html; 
http://www.businesswire.com/news/home/20140616005646/en/Waters-Introduces-Xevo-G2-
XS-QTof-Xevo-TQ-S]. 
 
 
3.2.2. Fungal Material 
 
 The strain KUFA 0207 was isolated from the marine sponge Stylissa flabelliformis 
which was collected, by scuba diving at a depth of 10-15 m, from the coral reef at 
Samaesarn Island (12°34’ 36.64” N 100°56’ 59.69” E) in the Gulf of Thailand, Chonburi 
Province, in April 2014. The sponge was washed with 1% sodium hypochlorite solution for 
1 min, followed by sterilized seawater 3 times, and then dried on sterile filter paper under a 
laminar flow hood, cut into small pieces (5 x 5 mm), and placed on a malt extract agar (MEA) 
plates containing 70% seawater and 300 mg/L of streptomycin sulfate. The plates were 
incubated at 28°C for 7 days, after which the hyphal tips were transferred onto a slant MEA 
and maintained as pure culture for further identification. The fungus was identified as 
Talaromyces stipitatus C.R. Benj., based on morphological characteristics, and was also 
confirmed by analysis sequence of the internal transcribed spacer (ITS) gene according the 
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procedure previously described (Zin et al., 2015). Its gene sequences were deposited in 
GenBank with accession number KU500028. The pure cultures were deposited as KUFA 
0207 at Kasetsart University Fungal Collection, Department of Plant Pathology, Faculty of 
Agriculture, Kasetsart Unversity, Bangkok, Thailand. The fungus was cultured for one week 
at 28°C in 10 Petri dishes (i.d. 90 mm) containing 25 mL of MEA. In order to obtain the 
mycelial suspension, the mycelial plugs were transferred to two 500 mL Erlenmeyer flasks 
containing 200 mL of potato dextrose broth, and then incubated on a rotary shaker at 120 
rpm at 28°C for one week. Fifty 1000 mL Erlenmeyer flasks, each containing 300 g of 
cooked rice, were autoclaved at 121°C for 15 min, and then incubated with 20 mL of mycelial 
suspension of T. stipitatus and incubated at 28°C for 30 days, after which the moldy rice 
was macerated in ethyl acetate for 7 days, and then filtrated. The ethyl acetate solution was 
concentrated under reduced pressure to yield 65.5 g of crude ethyl acetate extract. 
 
 
Figure 33. Colony of Talaromyces stipitatus C.R. Benj. (KUFA 0207) on male extract agar, 
14 days, 28°C (A), SEM of ascospores (B).  
 
 
3.2.2. Isolation, Purification of the Secondary Metabolites 
 
 The crude ethyl acetate (35 g) was applied on a column chromatography of silica 
gel (335 g) and eluted with mixtures of petrol-CHCl3, CHCl3-Me2CO, Me2CO and Methanol, 
250 mL fractions were collected as follow: Frs 1-133 (petrol-CHCl3, 1:1), 134-249 (petrol: 
CHCl3, 3:7), 250-314 (petrol-CHCl3, 1:9), 315-440 (CHCl3-Me2CO, 9:1), 441-511 (CHCl3-
Me2CO, 7:3), 512-546 (CHCl3-Me2CO, 1:1). Frs 156-170 were combined (382.7 mg) and 
crystallized in methanol to give palmitic acid (I) (20 mg). Frs 171-182 were combined (370 
mg) and purified by TLC (silica gel G254, CHCl3-petrol-EtOAc-HCO2H, 16:3:1:0.1) to give 
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compound talarosterone (V) (10.5 mg), palmitic acid (I) (21.7 mg) and ergosta-
4,6,8(14),22-tetraen-3-one (III) (23.3 mg). Frs 220-250 were combined (201.5 mg) and 
crystallized in MeOH to give ergosta-4,6,8(14),22-tetraen-3-one (III) (10.6 mg). Frs 315-
317 were combined (4.53 g) and applied over a column chromatography of silica gel (35 g) 
and eluted with mixture of petrol- CHCl3 and CHCl3-Me2CO, wherein 250 mL fractions were 
collected as follows: sfrs 1-101 (petrol- CHCl3, 1:1), 102-170 (petrol: CHCl3, 3:7), 171-296 
(petrol-CHCl3, 1:9), 297-311 (CHCl3-Me2CO, 9:1). Sfrs 19-38 were combined (329 mg) and 
applied over a column chromatography of Sephadex LH-20 (10 g) and eluted with a 1:1 
mixture of CHCl3: MeOH, to give forty 15 mL ssfrs. Ssfrs 8-37 were combined and purified 
by TLC (silica gel G254, CHCl3-petrol-EtOAc-HCO2H, 80:16.5:3.5:0.1) to give cyathisterone 
(IV) (12.2 mg). Sfrs 229-296 were combined (179 mg) and purified by TLC (silica gel G254, 
CHCl3-petrol-EtOAc-HCO2H, 80:15:5:0.1) to give emodin (VI) (10 mg). Frs 318-330 were 
combined (3.77 g) and applied over a column chromatography of silica gel (100 g) and 
eluted with mixture of petrol-CHCl3 and CHCl3-Me2OH, wherein 100 mL fractions were 
collected as follows: sfrs 1-118 (petrol-CHCl3, 1:1), 199-277 (petrol-CHCl3, 3:7), 278-289 
(petrol-CHCl3, 1:9), 290-471 (CHCl3), 472-589 (CHCl3-Me2CO, 9:1), 590-633 (CHCl3-
Me2CO, 7:3). Sfrs 238-395 were combined (473.7 mg) and crystallized in a mixture of CHCl3 
and petrol to give ergosterol-5,8-endoperoxide (II) (22 mg). Sfrs 477 (146.2 mg) was 
crystallized in a mixture of CHCl3 and petrol to give a reddish orange solid of 2, 2’-bis-(7-
methyl-1,4,5-trihydroxy-anthracene-9,10-dione) (XII) (9 mg). Sfrs 510-524 were 
combined (53 mg) and crystallized in CHCl3 to give yellow solid of fallacinol (IX) (21 mg). 
Frs 332-345 were combined (60.0 mg) and crystallized in a mixture of CHCl3 and MeOH to 
give 15.2 mg of secalonic acid A (XI). Frs 355-365 were combined (103.0 mg) and 
crystallized in a mixture of CHCl3 and MeOH to additional 10.5 mg of secalonic acid A (XI) 
whereas the mother liquor was further purified by TLC (silica gel G254, CHCl3-Me2CO-
HCO2H, 4:1:0.01) to give 8.5 mg of citreorosein (VIII). Frs 392-440 were combined (316 
mg) and crystallized in Me2CO to give questinol (VII) (10.7 mg). Frs 443-450 were 
combined and crystallized in Me2CO to give rheoemodin (X) (6 mg). 
 
 
3.2.3. Physical Characteristics and Spectroscopic Data 
 
 Palmitic acid (I): white solid; mp. 60-63°C; For 1H and 13C NMR spectra (DMSO, 
500.13 and 125.4 MHz), see Table 4; (+)-HRESIMS m/z 257.2484 (M+H)+, (calcd for 
C16H33O2, 257.2481). 
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 Ergosterol-5,8-endoperoxide (II); colorless crystal; mp. 180-182°C; For 1H and 13C 
NMR spectra (DMSO, 300.13 and 75.4 MHz) see Table 5. 
 
 Ergosta-4, 6, 8(14), 22-tetraen-3-one (III): white crystal; mp. 108-111°C; For 1H 
and 13C NMR spectra (CDCl3, 300.13 and 75.4 MHz), see Table 6. 
 
 Cyathisterone (IV): white crystal; mp. 200-202°C; [α]23D +200 (c 0.03, CHCl3); IR 
(KBr) υmax 2951, 1717, 1701, 1661, 1622, 1457, 1384, 1263 cm-1; For 
1H and 13C NMR 
data (CDCl3, 300.13 and 75.4 MHz), see Table 7; (+)-HRESIMS m/z 411.3262 (M+H)+, 
(calcd for C28H43O2, 411.3263). 
 
Talarosterone (V): white crystal; mp. 146-148°C; [α]23D +204 (c 0.04, CHCl3); IR 
(KBr) υmax 2956, 2873, 1689, 1670, 1593, 1458, 1411, 1276, 1260 cm-1; For 
1H and 13C 
NMR data (CDCl3, 300.13 and 75.4 MHz), see Table 8; (+)-HRESIMS m/z 425.3056 
(M+H)+, (calcd for C28H41O3, 425.3056). 
 
 Emodin (VI): orange solid; mp. 105-110°C; For 1H and 13C NMR spectra (DMSO, 
500.13 and 125.4 MHz) see Table 9. 
 
 Questinol (VII): orange solid; mp. 255-265°C; For 1H and 13C NMR spectra (DMSO, 
300.13 and 75.4 MHz) see Table 10; (+)-HRESIMS m/z 301.0713 (M+H)+, (calcd for 
C16H13O6, 301.0712). 
 
 Citreorosein (VIII); yellow solid; mp. 287-289°C; For 1H and 13C NMR spectra 
(DMSO, 500.13 and 125.4 MHz) see Table 11. 
 
 Fallacinol (IX); yellowish orange crystal; mp. 205-208°C; For 1H and 13C NMR 
spectra (DMSO, 500.13 and 125.4 MHz) see Table 12; (+)-HRESIMS m/z 301.0705 
(M+H)+, (calcd for C16H13O6, 301.0712). 
 
 Rheoemodin (X); brown solid; mp. 164-167°C; For 1H and 13C NMR spectra 
(DMSO, 300.13 and 75.4 MHz) see Table 13. 
 
 Secalonic acid A (XI); yellow crystal; mp. 268-270°C; For 1H and 13C NMR spectra 
(DMSO, 300.13 and 75.4 MHz) see Table 14; (+)-HRESIMS m/z 639.1733 (M+H)+, (calcd 
for C32H31O14, 639.1714). 
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 Bis-(7-methyl-1,4,5-trihydroxy-9,10-anthraquinone) (XII); reddish orange solid; 
mp. 258-260°C; [α]20D -100 (c 0.05, MeOH) and - 40 (c 0.05, dioxin); IR (KBr) υmax 3463, 
2359, 1622, 1550, 1480, 1457, 1247, 1207 cm-1; For 
1H and 13C NMR spectra (DMSO, 
500.13 and 125.4 MHz) see Table 15; (+)-HRESIMS m/z 539.0942 (M+H)+, (calcd for 
C30H19O10, 539.0978). 
 
 
3.2.4. X-ray Crystallographic Analysis of Compounds IV and V  
 
 Diffraction data were collected at 293 K with a Gemini Ultra equipped with CuKα 
radiation (λ = 1.54184 Å). The structures were solved by direct methods using SHELXS-97 
and refined with SHELXL-97 (Sheldrick, 2008). Carbon and oxygen atoms were refined 
anisotropically. Hydrogen atoms were either placed at their idealized positions using 
appropriate HFIX instructions in SHELXL, and included in subsequent refinement cycles, or 
were directly found from difference Fourier maps and were refined freely with isotropic 
displacement parameters. Full details of the data collection and refinement and tables of 
atomic coordinates, bond lengths and angles, and torsion angles have been deposited with 
the Cambridge Crystallographic Data Centre. 
 
 Cyathisterone (IV). Crystals were monoclinic, space group P21, cell volume 
1278.36(8) Å3 and unit cell dimensions a = 6.6142(2) Å, b = 6.46731(19) Å and c = 
29.8941(13) Å and angle β = 91.419(4)º (uncertainties in parentheses). The refinement 
converged to R (all data) = 6.96% and wR2 (all data) = 14.86%. CCDC 1527349. 
 
 Talarosterone (V). Crystals were orthorhombic, space group C2221, cell volume 
5091.3(10) Å3 and unit cell dimensions a = 8.4602(5) Å, b = 12.407(2) Å and c = 48.504(5) 
Å. The refinement converged to R (all data) = 9.72% and wR2 (all data) = 15.83%. CCDC 
1527335. 
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3.2.4. Anti-Obesity Assay 
 
 Compound VI-XI were dissolved in DMSO at a concentration of 5 mM and stored at 
-20°C until analyses. Anti-obesity activity of the compounds were analyzed with the 
zebrafish Nile red assay as described in Jones et al. (2008) with some modifications. 
Zebrafish adults and larvae were maintained under standard conditions at 28°C as defined 
in the zebrafish book available at ZFIN database (https://zfin.org/). In brief, zebrafish 
embryos were raised from 1 DPF (days post fertilization) in egg water (60 µg/ml marine sea 
salt dissolved in distilled H2O) with 200 µM PTU (1-phenyl-2-thiourea) to inhibit 
pigmentation. From 3 DPF to 5 DPF, zebrafish larvae were exposed to compounds at a 
final concentration of 5 µM with daily renewal of water and compounds in a 24-well plate 
with a density of 10-12 larvae/well. A solvent control (0.1% DMSO) and positive control 
(REV, resveratrol, final concentration 50 µM) were included in the assay. Lipids were 
stained with the Nile red overnight at the final concentration of 10 ng/ml. For imaging, the 
larvae were anaesthetized with the tricaine (MS-222, 0.03%) for 5 minutes and fluorescence 
analyzed with a fluorescence microscope (Leica DM6000B, Wetzlar, Germany). 
Fluorescence intensity was quantified in individual zebrafish larvae by ImageJ 
(https://imagej.nih.gov/ij/index.html). 
 
 
		
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4 
 
 
 
  
		 52	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
4. Results and Discussion 
 
4.1. Secondary Metabolites Isolated from Talaromyces stipitatus 
 
The crude ethyl acetate extract of the marine-derived fungus Talaromyces stipitatus 
(KUFA 0207) furnishes ten previously reported compounds including palmitic acid (I), 
ergosterol-5,8-endoperoxide (II), ergosta-4,6,8(14),22-tetraen-3-one (III), cyathisterone 
(IV), emodin (VI), questinol (VII), citreorosein (VIII), fallacinol (IX), rheoemodin (X), 
secalonic acid A (XI) and two previously undescribed compounds: talarosterone (V), and 
bis-(7-methyl-1,4,5-trihydroxy-9,10-anthraquinone) (XII). The structures of these 
compounds are showed in Figure 34. 
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Figure 34. Secondary metabolites isolated from the marine-derived Talaromyces stipitatus. 
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4.2. Identifications and Characterization of Secondary metabolites 
from the culture of Talaromyces stipitatus 
 
4.2.1. Structure Elucidation of Fatty Acid 
 
4.2.1.1. Palmitic acid (I) 
 
 
Figure 35. Structure of palmitic acid (I). 
 
Compound I was isolated as white solid (mp.60-63°C), and its molecular formula 
C16H32O2 was determined based on the (+)-HRESIMS m/z 257.2484 [M+H]+ (calculated 
257.2481), indicating one degree of unsaturation. The 13C NMR spectrum (Table 4) 
exhibited, in combination with DEPT and HSQC spectra, the signals of one carboxyl 
carbonyl at dC 179.5, several methylene sp3 at dC 34.0 (dH 2.35, t, J = 7.5 Hz), 31.9, 29.6, 
29.4, 29.3, 29.1, 24.7 (dH 1.63, q, J = 7.2 Hz), 22.7 and a cluster of peaks centered at dC 
29.7, as well as one terminal methyl group at dC 14.1 (dH 0.88, t, J = 7.0 Hz). Combination 
of the 1H and 13C NMR chemical shift values and multiplicities with the HRMS data revealed 
that compound I has, besides a methyl and carboxyl groups, fourteen methylene groups. 
Therefore, compound I was identified as palmitic acid which has been isolated from several 
fungal extracts including Penicillium atrovenetum (Gottlieb and Van Etten, 1964). 
 
 
Figure 36. Structure of palmitic acid with chemical shifts. 
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Table 4. 1H and 13C NMR (DMSO, 500.13 MHz and 125.4 MHz) and HMBC assignment for 
palmitic acid (I) 
Position dC, type dH, (J in Hz) COSY HMBC 
1 179.5, CO --- --- --- 
2 34.0, CH2 2.35, t (7.5)  H2-3 C-3,4 
3 24.7, CH2 1.63, q (7.2) H2-2,4 C-4 
4 29.4, CH2 1.25, m --- --- 
 29.69, CH2 1.25, m --- --- 
 29.66, CH2 1.25, m --- --- 
 29.65, CH2 1.25, m --- --- 
5-13 29.6, CH2 1.25, m --- --- 
 29.37, CH2 1.25, m --- --- 
 29.3, CH2 1.25, m --- --- 
 29.1, CH2 1.25, m --- --- 
14 31.9, CH2 1.25, m --- --- 
15 22.7, CH2 1.25, m --- --- 
16 14.1, CH3 0.88, t (7.0) H2-15 C-14,15 
OH-1 - 7.26, s --- --- 
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4.2.2. Structure Elucidation of Ergosterol Derivatives 
 
4.2.2.1. Ergosterol-5,8-endoperoxide (II) 
 
 
Figure 37. Structure of ergosterol-5,8-endoperoxide (II) 
 
 Compound II was isolated as colorless crystal (mp.180-182°C). The 13C NMR 
spectrum (Table 5) exhibited twenty-eight carbon signals which, through DEPTs and HSQC 
spectra, can be categorized as four methine sp2 (dC 135.4, 135.2, 132.3 and 130.7), two 
oxyquaternary sp3 (dC 82.2, 79.4), two quaternary sp3 (dC 44.6, 37.0), seven methine sp3 (dC 
66.5, 56.2, 51.7, 51.1, 42.8, 39.8 and 33.1), seven methylene sp3 (dC 39.3, 36.9, 34.7, 30.1, 
28.7, 23.4 and 20.6), four secondary methyl (dC 20.9, 20.0, 19.6, 17.6) and two tertiary 
methyl (dC 18.2, 12.8) groups. The 1H NMR spectrum, in conjunction with the COSY 
spectrum (Table 5), showed a pair of doublets of a cis double bond at dH 6.51, d (J = 8.5 
Hz; dC 130.7)/ dH 6.24, d (J = 8.5 Hz; dC 135.4), a pair of double doublets of a trans double 
bond at dH 5.23, dd (J = 15.2, 7.1 Hz; dC 132.3)/ 5.14, dd (J = 15.2, 7.9 Hz; dC 135.2), two 
methyl singlets at dH 0.88 (dC 18.2) and dH 0.82 (dC 12.8), and four methyl doublets at dH 
1.00, d (J = 6.6 Hz; dC 20.9), dH 0.91, d (J = 6.8 Hz; dC 17.6), dH 0.82, d (J = 6.9 Hz; dC 19.6) 
and dH 0.81, d (J = 6.9 Hz; dC 20.0). 
 
 The general features of the 1H and 13C NMR spectra of II resembled those of 
ergosterol (Gao et al., 2003). The presence of the (3E)-5,6-dimethylhept-3-en-2-yl side 
chain, similar to that of ergosterol, was evidenced by the COSY correlations (Table 5) from 
the double doublet at dH 5.23 (J = 15.2, 7.1, H-23; dC 132.3) to the multiplet at dH 1.85 (H-24; 
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dC 42.8), from the double doublet at dH 5.14 (J = 15.2, 7.9, H-22; dC 135.2) to the multiplet at 
dH 2.10 (H-20; dC 39.8), from the methyl doublet at dH 1.00 (J = 6.6 Hz CH3-21; dC 20.9) to H-
20, from the multiplet at dH 1.85 (H-24; dC 42.8) to H-23 and the methyl doublet at dH 0.91 (J 
= 6.8, CH3-26; dC 17.6), as well as from the multiplet at dH 1.45 (H-25; dC 33.1) to the two 
methyl doublets at dH 0.82 (J = 6.9 Hz CH3-27; dC 19.6) and dH 0.81 (J = 6.9 Hz, CH3-28; dC 
20.0) (Figure 38). 
 
  
Figure 38. COSY correlations ( ) of the protons of the (3E)-5,6-dimethylhept-3-en-2-
yl side chain. 
 
 This structure was supported by the HMBC correlations from H3-21 to C-17 (dC 56.2), 
C-20 (dC 39.8), C-22 (dC 135.2), from H-22 to C-24 (dC 42.8), from H-23 to C-20, from H-24 
to C-22, 23 (dC 132.3), 25 (dC 31.1), 26 (dC 17.6), 28 (dC 20.0), from H3-26 to C-23, H3-27 to 
C-24, 25, 28 and from H3-28 to C-24, 25, 27 (dC 19.6) (Figure 39). 
 
 
Figure 39. HMBC correlations ( ) of the (3E)-5,6-dimethylhept-3-en-2-yl side chain. 
 
 The remaining 19 carbons that belong to the β-hydroxyandrostane skeleton, are 
similar to that of ergosterol. Since the 1H and 13C NMR of II displayed two olefinic protons 
of a cis double bond at dH 6.24, d (J = 8.5 Hz; dC 135.4) and dH 6.51, d (J = 8.5 Hz; dC 130.7), 
two oxygenated quaternary sp3 carbons at dC 79.4 (C-8) and dC 82.2 (C-5) instead of two 
endocyclic conjugated double bonds, suggested that II is ergosterol-5,8-endoperoxide 
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(Figure 40). This hypothesis was supported by the HMBC correlations from H3-19 (dH 0.88, 
s) to C-5 (dC 82.2) and C-10 (dC 37.0), H-4 (dH 2.11, ddd, J = 13.8, 5.2, 1.8 Hz; dC 36.9) to C-
3 (dC 66.5) and C-5, from H-6 (dH  6.24, d, J = 8.5 Hz; dC 135.4) to C-5, C-7 (dC 130.7), C-8 
(dC 79.4), C-10, and from H-7 (dH  6.51, d, J = 8.5 Hz; dC 130.7) to C-5, C-6, C-8, C-9 (dC 
51.1) and C-14 (dC 51.7). 
 
 
Figure 40. Key HMBC correlations ( ) of the 3β-hydroxyandrostane. 
 
Literature search revealed that ergosterol-5,8-endoperoxide was isolated from 
different parts of flowering plants such as flowers of Erigeron annuus L. (Kim et al., 2005) 
and from the aerial parts of Ajuga remota Benth. (Cantrell et al., 1999). Moreover, it has 
been isolated from the extract of fruiting bodies of the fungi Armillariella mellea (Kim et al., 
1999) and Lactarius hatsudake (Zhang et al., 2007). 
 
It is worth mentioning that the chemical shift values assigned for C-5/C-8 and C-6/C-
7 of ergosterol-5,8-endoperoxide, isolated from flowers of Erigeron annuus L., (Kim et al., 
2005) were not correct. The correct assignment of the carbons and protons of ergosterol-
5,8-endoperoxide, which is based on HMBC correlations, is shown in Table 5. 
 
 
 
 
 
CH3
CH3
CH3
CH3
HO
H3C
O
O
CH3
H
H
H
H
82.266.5
36.9
0.88, s
51.1
79.4
135.4
130.7
6.51, d (8.5)
6.24, d (8.5)
37.0
H
H H
3.97, m
2.11, ddd (13.8, 5.2, 1.8)
1.91, m
51.7
H
		 59	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
Table 5. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz) and HMBC assignment for 
ergosterol-5,8-endoperoxide (II). 
Position dC, type dH, mult. (J in Hz) COSY HMBC 
1 39.3, CH2 1.22, m/ 1.95, m --- --- 
2 30.1, CH2 1.53, m/ 1.83, m H-3 --- 
3 66.5, CH 3.97, m H-2, 4 --- 
4 36.9, CH2 1.91, m/ 2.11, ddd 
(13.8, 5.2, 1.8) 
H-3 C-3, 5 
5 82.2, C --- --- --- 
6 135.4, CH 6.24, d (8.5) H-7 C-5, 7, 8, 10 
7 130.7, CH 6.51, d (8.5) H-6 C-5, 6, 8, 9, 14 
8 79.4, C --- --- --- 
9 51.1, CH 1.48, m --- --- 
10 37.0, C --- --- --- 
11 20.6, CH2 1.39, m/ 1.58, m --- --- 
12 34.7, CH2 1.69, m/ 1.95, m --- C-8, 10 
13 44.6, C --- --- --- 
14 51.7, CH 1.55, m --- --- 
15 28.7, CH2 1.35, m/ 1.75, m --- --- 
16 23.4, CH2 1.22, m/ 1.50, m --- --- 
17 56.2, CH 1.21, m H-20 --- 
18 12.8, CH3 0.82, s --- C-13, 14, 17, 20 
19 18.2, CH3 0.88, s --- C-5, 10 
20 39.8, CH 2.10, m H-17, 21, 
22 
--- 
21 20.9, CH3 1.00, d (6.6) H-20 C-17, 20, 22 
22 135.2, CH 5.14, dd (15.2, 7.9) H-20 C-24 
23 132.3, CH 5.23, dd (15.2, 7.1) H-24 C-20 
24 42.8, CH 1.85, m H-23, 26 C-22, 23, 25, 26, 
28 
25 33.1, CH 1.45, m H-27, 28 --- 
26 17.6, CH3 0.91, d (6.8) H-24 C-23 
27 19.6, CH3 0.82, d (6.9) H-25 C-24, 25, 28 
28 20.0, CH3 0.81, d (6.9) H-25 C-24, 25, 27 
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4.2.2.2. Ergosta-4,6,8(14),22-tetraen-3-one (III) 
 
 
Figure 41. Structure of ergosta-4,6,8(14),22-tetraen-3-one (III). 
 
 Compound III was isolated as white crystals (mp. 108-111°C). The 13C NMR 
spectrum (Table 6) exhibited the presence of 28 carbon signals which, through DEPTs and 
HSQC spectra, were identified as one conjugated ketone carbonyl (dC 199.6), three 
quaternary sp2 (dC 164.4, 156.2 and 124.4), five methine sp2 (dC 135.0, 134.0, 132.5, 124.5 
and 123.0), two quaternary sp3 (dC 44.0 and 36.8), five methine sp3 (dC 55.7, 44.3, 42.9, 39.3 
and 33.1), six methylene sp3 [dC 35.6, 34.1 (2C), 27.7, 25.4 and 19.0], two tertiary methyl 
(dC 18.9 and 16.7), and four secondary methyl (dC 21.2, 20.0, 19.7 and 17.7) groups. The 1H 
NMR spectrum (Table 6) showed a pair of doublets of a cis double bond at dH 6.61 (J = 9.5 
Hz; dC 134.0)/ dH 6.03 (J = 9.5 Hz; dC 124.5), a pair of double doublets of a trans double bond 
at dH 5.26 (J = 15.2, 7.3 Hz; dC 132.5)/ dH 5.20 (J = 15.2, 8.1 Hz; dC 135.0), one singlet of a 
trisubstituted double bond at dH 5.74, s (dC 123.0), two methyl singlets at dH 1.00 (dC 16.7) 
and dH 0.96 (dC 18.9), and four methyl doublets at dH 1.06 (J = 6.7 Hz; dC 21.2), dH 0.93 (J = 
6.8 Hz; dC 17.7), dH 0.85 (J = 6.8 Hz; dC 20.0) and dH 0.83 (J = 6.8 Hz; dC 19.7).  
 
The general features of the 1H and 13C NMR spectra of compound III resembled 
those of ergosterol (Gao et al., 2003). The presence of the (3E)-5,6-dimethylhept-3-en-2-yl 
side chain, similar to that of ergosterol, was evidenced by the COSY correlations from the 
double doublet at dH 5.26 (J = 15.2, 7.3 Hz, H-23) to the double doublet at dH 5.20 (J = 15.2, 
8.1 Hz, H-22) and a multiplet at dH 1.85 (H-24; dC 42.9), from H-22 to H-23 and a multiplet 
at dH 2.13 (H-20; dC 39.3), from the methyl doublet at dH 1.06 (J = 6.7 Hz, CH3-21; dC 21.2) 
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to H-20, from the methyl doublet at dH 0.93 (J = 6.8 Hz, CH3-26; dC 17.7) to H-24, as well as 
from the doublets at dH 0.85 (J = 6.8 Hz, CH3-27; dC 20.0) and dH 0.83 (J = 6.8 Hz, CH3-28; 
dC 19.7) to the multiplet at dH 1.48 (H-25; dC 33.1) (Figure 42.). 
 
 
Figure 42. COSY correlations ( ) of the protons of the (3E)-5,6-dimethylhept-3-en-2-
yl side chain. 
 
 This was supported by the HMBC correlations from H3-21 to C-20 and C-22, from 
H-22 to C-21, 23, 24, from H-23 to C-20, 22, 24, from H3-26 to C-23, 24, 25, from H3-27 to 
C-24, 25, 28 and from H3-28 to C-24, 25, 27 (Figure 43.). 
 
 
Figure 43. Key HMBC correlations ( ) for the (3E)-5,6-dimethylhept-3-en-2-yl side 
chain of III. 
 
 Taking into account the presence of the trans double bond and four secondary 
methyl groups in the side chain, the cis double bond, the trisubstituted double bond and the 
two tertiary methyl groups have to be located in the cyclopentanoperhydrophenanthrene 
nucleus of compound III.  
 
Since the HMBC spectrum exhibited correlations from both H3-21 and the tertiary 
methyl singlet at dH 0.96 (dC 18.9) to the methine sp3 carbon at dc 55.7, the singlet at dH 0.96 
(dC 18.9) and the methine sp3 carbon at dc 55.7 were assigned to CH3-18 and CH-17, 
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respectively. Therefore, another tertiary methyl singlet (dH 1.00/ dC 16.7) was assigned to 
CH3-19. The fact that both H3-19 and the singlet at dH 5.74 (dC 123.0) exhibited cross peaks 
to the quaternary sp3 carbon at dC 36.8, while the H3-19 also showed HMBC cross peak to 
the quaternary sp2 carbon at dC 164.4 (C-5), the trisubstituted double bond was placed 
between C-4 and C-5. Therefore, the singlet at dH 5.74 was assigned to H-4, whereas the 
carbons at dC 36.8, dC 123.0 and dC 164.4 were assigned to C-10, C-4 and C-5, respectively. 
Moreover, the HMBC spectrum (Table 6) also exhibited correlations from the proton of the 
cis double bond at dH 6.03 d (J = 9.5 Hz; dC 124.5) to C-10, C-4, C-5 and the quaternary sp2 
carbon at dC 124.4 as well as from another proton of the cis double bond at dH 6.61 d (J = 
9.5 Hz; dC 134.0) to C-5, the quaternary sp2 carbon at dC 156.2 (C-14) and methine sp3 
carbon at dC 44.3 (C-9). Therefore, the cis double bond was placed between C-6 (dC 124.5) 
and C-7 (134.0), while the tetrasubstituted double bond was located between C-8 (dC 124.4) 
and C-14 (dC 156.2). This was supported also by the HMBC correlations from H3-19 to C-9 
and from H3-18 to C-14.  
 
Taking into account the number of carbon atoms, the 1H and 13C chemical shift 
values and the COSY and HMBC correlations, the structure of compound III was identified 
as ergosta-4,6,8(14), 22-tetraen-3-one. Ergosta-4,6,8(14), 22-tetraen-3-one has been 
isolated from several fungi including Polyporus umbellatus, an edible species of a 
mushroom, which is a widely used as anti-aldosteronic diuretic in Traditional Chinese 
Medicine (Zhao et al., 2009). This compound was also reported from the marine sponge 
associated fungus Talaromyces trachyspermus from the Gulf of Thailand (Kuml et al., 2014) 
as well as from the marine sponge Dysidea herbacea which was collected from the 
Lakshadweep Islands, Indian Ocean (Kobayashi et al., 1992). 
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Figure 44. 1H and 13C assignments for III. 
 
Table 6. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz) and HMBC assignment for 
ergosta-4,6,8(14), 22-tetraen-3-one (III). 
Position dC, type dH, mult. (J in Hz) COSY HMBC 
1 34.1, CH2 1.09, m 
2.08, m 
--- --- 
2 34.1, CH2 2.48, m --- C-3 
3 199.6, CO --- --- --- 
4 123.0, CH 5.74, s --- C-2, 5, 6, 10, 19 
5 164.4, C --- --- --- 
6 124.5, CH 6.03, d (9.5) H-7 C-4, 5, 8, 10 
7 134.0, CH 6.61, d (9.5) H-6 C-5, 8, 9, 14 
8 124.4, C --- --- --- 
9 44.3, CH 2.18, m --- C-14 
10 36.8, C --- --- --- 
11 19.0, CH2 1.80, m 
2.03, m 
--- 
--- 
C-8 
--- 
12 35.6, CH2 1.29, m 
2.08, m 
--- 
--- 
C-9, 13 
--- 
13 44.0, C --- --- --- 
14 156.2, C --- --- --- 
15 25.4, CH2 2.39, m --- C-14 
16 27.7, CH2 1.50, m --- --- 
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CH3
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19.7
0.83, d (6.8)
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5.20, dd
(15.2, 8.1)
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1.00, s
16.7
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Position dC, type dH, mult. (J in Hz) COSY HMBC 
1.70, m --- C-13 
17 55.7, CH 1.25, m --- --- 
18 18.9, CH3 0.96, s --- C-13, 14, 17 
19 16.7, CH3 1.00, s --- C-1, 5, 9, 10 
20 39.3, CH 2.13, m H-22 C-22, 23 
21 21.2, CH3 1.06, d (6.7) H-20 C-17, 20, 22 
22 135.0, CH 5.20, dd (15.2, 8.1) H-20, 23 C-21, 23, 24 
23 132.5, CH 5.26, dd (15.2, 7.3) H-22, 24 C-20, 22, 24 
24 42.9, CH 1.85, m H-23,25,26 C-23, 25, 26, 28 
25 33.1, CH 1.48, m H-27, 28 --- 
26 17.7, CH3 0.93, d (6.8) H-24 C-23, 24, 25 
27 20.0, CH3 0.85, d (6.8) H-25 C-24, 25, 28 
28 19.7, CH3 0.83, d (6.8) H-25 C-24, 25, 27 
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4.2.2.3. Cyathisterone (IV) 
 
 
Figure 45. Structure of cyathisterone (IV) 
 
Compound IV was isolated as white crystals (mp. 200-202 °C), and its molecular 
formula C28H42O2 was determined based on the (+)-HRESIMS m/z 411.3262 [M+H]+ 
(calculated 411.3263), indicating eight degrees of unsaturation. The IR spectrum showed 
absorption bands for ketone carbonyl (1717 cm-1), conjugated ketone carbonyl (1661 cm-1) 
and olefin (1622 cm-1) groups. The general feature of the 1H and 13C NMR spectra of 
compound IV revealed that it was an ergosterol derivative.  
 
The 13C NMR spectrum (Table 7) exhibited twenty-eight carbon signals which, in 
conjunction with DEPTs and HSQC spectra, can be categorized as one ketone carbonyl (dC 
211.0), one conjugated ketone carbonyl (dC 198.3), one quaternary sp2 (dC 163.8), three 
methine sp2 (dC 134.9, 132.6 and 122.8), two quaternary sp3 (dC 44.5 and 38.3), seven 
methine sp3 (dC 56.1, 55.7, 54.6, 49.6, 42.8, 40.3 and 33.1), seven methylene sp3 (dC 38.6, 
38.2, 37.3, 37.0, 27.9, 22.6 and 22.0), two tertiary methyl (dC 12.8 and 12.7) and four 
secondary methyl (dC 21.1, 20.0, 19.7 and 17.6) groups. 
 
The 1H NMR spectrum (Table 7) showed a broad triplet of the olefinic proton of the 
trisubstituted double bond at dH 5.78 (J = 2.3 Hz), two doublets of the trans double bond at 
dH 5.25 (J = 15.2, 7.2 Hz) and 5.16 (J = 15.2, 7.9 Hz), two singlets of tertiary methyls at dH 
1.08 and 0.65, and four doublets of secondary methyls at dH 1.50 (J = 6.6 Hz), dH 0.92 (J = 
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6.8 Hz), dH 0.82 (J = 6.8 Hz) and dH 0.84 (J = 6.8 Hz). That IV had the same (3E)-5,6-
dimethylhept-3-en-2-yl side chain as ergosterol (Martinez, 2016) and ergosta-4,6,8(14),22-
tetraen-3-one (III) (Kuml et al., 2014), was evidenced by COSY correlations from CH3-21 
(dH 1.05, d, J = 6.6 Hz) to H-20 (dH 2.04, m), from H-22 (dH 5.16, dd, J = 15.2, 7.9 Hz) to H-
20 and H-23 (dH 5.25, dd, J = 15.2, 7.2 Hz), from H-23 to H-22 and H-24 (dH 1.85, m), from 
H3-26 (dH 0.92, d, J = 6.8 Hz) to H-24, and from H3-27 (dH 0.82, d, J = 6.8 Hz), H3-28 (dH 
0.84, d, J = 6.8 Hz) and H-24 to H-25 (dH 1.48, m), as well as by HMBC correlations from 
H3-27 and H3-28 to C-24 (dC 42.8), C-25 (dC 33.1) and CH3-26 (dC 17.6), from H3-26 to C-23 
(dC 132.5), C-24 and C-25, and from H3-21 to C-20 (dC 40.3), C-22 (dC 134.9) and C-17 (dC 
56.1) (Table 7 and Figure 46).  
 
The trisubstituted double bond was located between C-7 and C-8, and the 
conjugated ketone carbonyl was on C-6 of the cyclopentanoperhydrophenanthrene moiety 
was supported by the COSY correlations from H-7 (dH 5.78, brt, J = 2.3 Hz) to H-9 (dH 2.26, 
m) and H-14 (dH 2.09, m), as well as by the HMBC correlations from H-7 to C-9 (dC 49.6), 
from H3-19 to C-5 (dC 54.6), C-9 and C-10 (dC 38.3), from H-5 (dH 2.64, dd, J = 12.8, 4.5 Hz) 
to C-6 (dC 198.3). Since H-2 (dH 2.33, m and 2.38, m; dC 37.3) and H-4 (dH 2.59, m; dC 37.0) 
exhibited cross peaks to the carbonyl carbon at dC 211.0, another ketone function was 
placed on C-3 (Table 7 and Figure 46). 
 
Consequently, the structure of IV was elucidated as ergosta-7, 22-dien-3,6-dione. 
The structure and the stereochemistry of IV were confirmed by X-ray analysis (Figure 47), 
and since the diffraction data were collected with the Gemini PX Ultra equipped with CuKa 
radiation, it was possible to establish the absolute configurations of C-5, C-9, C-10, C-13, 
C-14, C-17, C-20 and C-24, respectively, as 5S, 9R, 10R, 13R, 14R, 17R, 20S, 24R. From 
all data, IV was elucidated as cyathisterone which has been isolated from Calvatia 
cyathiformis (Kawahara et al., 1994). 
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Figure 46. Key COSY ( ) and HMBC ( ) correlations of IV. 
 
 
Figure 47. ORTEP diagram of IV. 
 
Table 7. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz) and HMBC assignment for 
cyathisterone (IV). 
Position dC, type dH, mult. (J in Hz) COSY HMBC 
1 38.2, CH2 1.70, m 
2.14, m 
--- --- 
2 37.3, CH2 2.33, m 
2.38, m 
--- 
 
CO-3 
3 211.0, CO --- --- --- 
4 37.0, CH2 2.59, m H-5 CO-3 
5 54.6, CH 2.64, dd (12.8, 4.5) H-4 CO-6 
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Position dC, type dH, mult. (J in Hz) COSY HMBC 
6 198.3, CO --- --- --- 
7 122.8, CH 5.78, brt (2.3) H-9, 14 C-9 
8 163.8, C --- --- --- 
9 49.6, CH 2.26, m H-7, 11 --- 
10 38.3, C --- --- --- 
11 22.0, CH2 1.72, m 
1.85, m 
--- 
--- 
--- 
--- 
12 38.6, CH2 1.45, m 
2.14, m 
--- 
--- 
--- 
--- 
13 44.5, C --- --- --- 
14 55.7, CH 2.09, m H-9, 15 --- 
15 22.6, CH2 1.50, m 
1.60, m 
--- 
--- 
--- 
--- 
16 27.9, CH2 1.37, m 
1.79, m 
--- 
--- 
--- 
--- 
17 56.1, CH 1.36, m H-16, 20 --- 
18 12.7, CH3 0.65, s --- --- 
19 12.8, CH3 1.08, s --- C-5, 9, 10 
20 40.3, CH 2.04, m H-21, 22 --- 
21 21.1, CH3 1.05, d (6.6) H-20 C-17, 20, 22 
22 134.9, CH 5.16, dd (15.2, 7.9) H-20, 23 C-20, 25 
23 132.6, CH 5.25, dd (15.2, 7.2) H-22, 24 C-20, 24 
24 42.8, CH 1.85, m H-22, 25, 26 C-22, 23 
25 33.1, CH 1.48, m H-24, 27, 28 C-23 
26 17.6, CH3 0.92, d (6.8) H-24 C-23, 24, 25 
27 20.0, CH3 0.82, d (6.8) H-25 C-24, 25, 26, 28 
28 19.7, CH3 0.84, d (6.8) H-25 C-24, 25, 26, 27 
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4.2.2.4. Talarosterone (V) 
 
 
Figure 48. Structure of talarosterone (V). 
 
 The molecular formula C28H40O3 of V, a white crystal (mp. 146-148 °C), was 
established based on the (+)-HRESIMS m/z 425.3056 [M+H]+ (calculated 425.3056), 
indicating nine degrees of unsaturation. The IR spectrum showed absorption bands for 
conjugated ketone carbonyl (1689, 1670 cm-1) and olefin (1593 cm-1) groups. Like IV, the 
13C NMR spectra of V (Table 8) showed the presence of twenty eight carbon signals which 
can be classified, by DEPTs and HSQC spectra, as two conjugated ketone carbonyl (dC 
199.5 and 195.9), one quaternary sp2 (dC 155.0), three methine sp2 (dC 135.0, 132.5 and 
129.2), one oxyquaternary sp3 (dC 66.2), two quaternary sp3 (dC 44.3 and 36.8), seven 
methine sp3 (dC 56.1, 56.0, 51.8, 43.9, 42.8, 40.0 and 33.0), six methylene sp3 (dC 39.0, 37.1, 
33.8, 27.7, 20.7 and 18.7), two tertiary methyl (dC 21.8 and 12.4) and four secondary methyl 
(dC 21.0, 20.0, 19.6 and 17.6) groups. 
 
The 1H NMR spectrum (Table 8) exhibited a doublet of an olefinic proton at dH 6.66 
(J = 0.8 Hz), a singlet of one proton at dH 3.20, two singlets of the tertiary methyls at dH 1.50 
and 0.89, in addition to the proton signals of the (3E)-5,6-dimethylhept-3-en-2-yl side chain 
[dH 0.82, d, J = 6.8 Hz (H3-27), dH 0.84, d, J = 6.8 Hz (H3-28), dH 1.04, d, J = 6.8 Hz (H3-21), 
dH 5.15, dd, J = 15.3, 7.3 Hz (H-22) and dH 5.25, dd, J = 15.3, 8.0 Hz (H-23)]. As both H3-21 
and the methyl singlet at dH 0.89 showed HMBC cross peaks to C-17 (dC 56.0), the methyl 
singlet dH 0.89 was assigned to CH3-18. Therefore, another methyl singlet (dH 1.50; dC 21.8) 
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was assigned to CH3-19. Since the HMBC spectrum (Table 8, Figure 49) also exhibited 
cross peaks from both H3-19 and the doublet of the olefinic proton at dH 6.66 (J = 0.8 Hz, H-
4) to the quaternary sp2 carbon at dC 155.0, the double bond was placed between C-4 (dC 
129.2) and C-5 (dC 155.5). Moreover, H3-19 also showed HMBC cross peaks to the carbon 
signals at dC 43.9, 37.1 and 36.8, therefore they were assigned to C-9, C-1 and C-10, 
respectively. On the other hand, the carbons at dC 44.3 and 51.8 were assigned to C-13 and 
C-14 since both showed HMBC cross peaks to H3-18. Moreover, the HMBC spectrum also 
exhibited cross peaks from the singlet at dH 3.20 to C-5, C-14, the carbons at dC 66.2 and dC 
195.9, the carbon at dC 66.2 was assigned to C-8 and one of the conjugated carbonyl carbon 
(dC 195.9) was placed on C-6. This was supported by the HMBC cross peak from H-4 to C-
6. Therefore, another conjugated carbonyl group (dC 199.5) must be on C-3. The fact that 
there was one more oxygen atom to be accounted for, along with the presence of the 
oxyquaternary carbon (dC 66.2), the epoxide function was placed between C-7 and C-8. 
Therefore, the structure of V was elucidated as 7, 8-epoxyergosta-4, 22-dien-3, 6-dione. 
 
 
Figure 49. Key COSY ( ) and HMBC ( ) correlations of V. 
 
 In order to determine the stereochemistry of V, the ROESY spectrum was obtained. 
As the ROESY spectrum (Table 8, Figure 50) showed cross peaks from H-7 to H-9, H-14 
and H-15 (dH 1.25, m) but not to H3-19, it was concluded that the epoxide ring was on the 
same face as CH3-19, i. e. the relative configurations of C-7 and C-8 are 7R and 8R, 
respectively. 
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Figure 50. Key ROESY correlations (  ) of V. 
 
 Since V was obtained in a suitable crystal, X-ray analysis was carried out, and the 
ORTEP view shown in Figure 51 revealed that the absolute configurations of C-7, C-8, C-
9, C-10, C-13, C-14, C-17, C-20 and C-24 are 7R, 8R, 9R, 10R, 13R, 14R, 17R, 20S and 
24R. A literature search indicated that V has never been previously reported. Therefore, it 
is a new compound and was named talarosterone. 
 
 
Figure 51. ORTEP diagram of V. 
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Table 8. 1H and 13C NMR (CDCl3, 300.13 MHz and 75.4 MHz) and HMBC assignment for 
talarosterone (V). 
Position dC, type dH, mult. (J in Hz) COSY ROESY HMBC 
1a 
b 
37.1, CH2 1.81, m 
2.18, m 
--- --- --- 
2a 
b 
33.8, CH2 2.50, m 
2.64, dd (17.9, 7.2) 
H-1 
H-1 
--- --- 
3 199.5, CO --- --- --- --- 
4 129.2, CH 6.66, d (0.8) --- --- C-2, 3, 5 
5 155.0, C --- --- --- --- 
6 195.9, CO --- --- --- --- 
7 56.1, CH 3.20, s --- H-9, 14, 15 C-5, 6, 8, 14 
8 66.2, C --- --- --- --- 
9 43.9, CH 1.90, m --- --- --- 
10 36.8, C --- --- --- --- 
11 20.7, CH2 1.85, m --- --- --- 
12 39.0, CH2 1.21, m 
1.40, m 
--- --- --- 
13 44.3, C --- --- --- --- 
14 51.8, CH 1.94, m --- --- --- 
15 18.7, CH2 1.25, m --- --- --- 
16 27.7, CH2 1.34, m 
1.75, m 
--- --- --- 
17 56.0, CH 1.30, m --- --- --- 
18 12.4, CH3 0.89, s --- --- C-12, 13, 14, 17 
19 21.8, CH3 1.50, s --- 1b, 2b C-1, 5, 9, 10 
20 40.0, CH 2.04, m --- --- --- 
21 21.0, CH3 1.04, d (6.8) H-20 --- C-17, 20, 22 
22 135.0, CH 5.15, dd (15.3, 7.3) H-20, 23 --- C-21, 24 
23 132.5, CH 5.25, dd (15.3, 8.0) H-22, 24 --- C-20, 24, 25, 26 
24 42.8, CH 1.85, m --- --- C-22, 23 
25 33.0, CH 1.48, m --- --- --- 
26 17.6, CH3 0.92, d (6.8) H-24 --- C-23, 24, 25 
27 20.0, CH3 0.82, d (6.8) H-25 --- C-24, 25, 28 
28 19.6, CH3 0.84, d (6.8) H-25 --- C-24, 25, 27 
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4.2.3. Structure Elucidation of Anthraquinones 
 
4.2.3.1. Emodin (VI) 
 
 
Figure 52. Structure of emodin (VI). 
 
Compound VI was isolated as orange solid (mp. 105-110 °C). The 13C NMR, DEPT 
and HSQC spectra (Table 9) exhibited the signals of two conjugated ketone carbonyls (dC 
181.6 and 189.2), two sp2 oxyquaternary (dC 164.6 and 161.4), four sp2 quaternary (dC 148.0, 
135.0, 132.9 and 113.5), four sp2 methine (dC 124.1, 120.4, 109.2 and 108.1), and one 
methyl (dC 21.5) groups, respectively. Since the intensity of the sp2 oxyquaternary carbon 
at dC 161.4 is nearly double of that at dC 164.6, the carbon signal at dC 161.4 must correspond 
to two sp2 oxyquaternary carbons. 
 
The 1H NMR spectrum (Table 9) exhibited three broad singlets at dH 7.50, 7.17 and 
6.56, and one doublet at dH 7.10, d, J = 2.0 Hz of the aromatic protons, and one singlet of 
the aromatic methyl group at dH 2.42, in addition to a broad singlet (integrated for two 
protons) of the hydrogen-bonded hydroxyl groups at dH 12.11. The COSY spectrum (Table 
9) showed correlations from the aromatic proton at dH 7.50, brs, to the aromatic proton at dH 
7.17, brs and the methyl proton at dH 2.42, s, while the latter also showed correlations to 
the aromatic proton at dH 7.50, brs and the methyl protons at dH 2.42, s. Therefore, the 
presence of a 1, 2, 3, 5-tetrasubstituted benzene ring with the methyl group on C-5 (Figure 
53 A) was suggested. The COSY spectrum also showed a correlation between another pair 
of aromatic protons, i.e. dH 7.10, d (J = 2.0 Hz) and dH 6.56, brs. Therefore, another 1,2,3,5-
tetrasubstituted benzene ring was present (Figure 53 B) in the structure of VI. 
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Figure 53. Key COSY correlations ( ) of VI.  
 
The HMBC spectrum (Table 9) exhibited cross peaks from the proton at dH 7.50, 
brs, to the methyl carbon at dC 21.5, aromatic carbons at dC 113.5 (C), 124.1 (CH) and the 
carbonyl carbon at dC 181.6, as well as from the proton singlet at dH 7.17 to the methyl 
carbon at dC 21.5, aromatic carbons at dC 113.5 (C), 120.4 (CH) and 161.4 (C). Therefore, 
it is clear that the ketone carbonyl group (dC 181.6) was on C-1 and the hydroxyl group was 
on C-6 (dC 161.4) (Figure 54 C). This was supported by the HMBC correlations of the singlet 
of the methyl protons (dH 2.42) to the aromatic carbons at dC 120.4 (CH), 124.1 (CH) and 
148.0 (C), respectively. Moreover, the HMBC spectrum also showed cross peaks from the 
aromatic proton at dH 7.10, d (J = 2.0 Hz) to the ketone carbonyl group (dC 181.6) and the 
aromatic carbon at dC 108.1, as well as from the aromatic proton at dH 6.56, brs to the 
aromatic carbons at dC 109.2 (CH) and 161.4 (C). Therefore, the ketone carbonyl (dC 181.6) 
was on C-3 and the hydroxyl groups were on C-1 (dC 161.4) and C-5 (dC 164.6) of this 
1,2,3,5-tetrasubstituted benzene ring (Figure 54 D), respectively. 
 
 
Figure 54. The HMBC correlations ( ) of VI. 
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Since the chemical shift value of another ketone carbonyl carbon (dC 189.2) was 
nearly 8 ppm higher than the conjugated carbon at dC 181.6, it must be flanked by phenolic 
hydroxyl groups which form the hydrogen bonds with this conjugated carbonyl. Therefore, 
the two substituted benzene rings were linked by another carbonyl group forming an 
anthraquinone scaffold (Figure 55). 
 
 
Figure 55. Structure of emodin (VI) indicating 1H and 13C chemical shifts. 
 
 Taking together all these NMR data and correlations, the structure of VI was 
deduced as 1, 3, 8-trihydroxy-6-methylanthracene-9,10-dione. 
 
  Literature search revealed that VI, which is widely known as emodin, has been 
isolated from several natural sources including the endophytic fungus Aspergillus versicolor 
isolated from red sea algae (Hawas et al., 2012), the marine derived-fungus Penicillium 
oxalicum (Wang et al., 2014). Emodin has been isolated from lichenized fungi of the genus 
Xanthoria (Manojlovic et al., 2000) and also from the genus Heterodermia (Cohen and 
Towers, 1995). Moreover, emodin has been isolated from several plants including Cassia 
obtusifolia (Yang et al., 2003), Polygonum cuspidatum (Jayasuriya et al., 1992) and from 
Rhamnus triquerta wall (Goel et al., 1991). 
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Table 9. 1H and 13C NMR (DMSO, 500.13 MHz and 125.4 MHz) and HMBC assignment for 
emodin (VI). 
Position dC, type dH, mult. (J in Hz) COSY HMBC 
1 161.4, C --- --- --- 
2 108.1, CH 6.56, brs H-4 C-1, 4 
3 164.6, C --- --- --- 
4 109.2, CH 7.10, d (2.0) H-2 C-2, 10 
4a 132.9, C --- --- --- 
5 120.4, CH 7.50, brs H-7, H3-6 C-7, 8a, 10, CH3-6 
6 148.0, C --- --- --- 
7 124.1, CH 7.17, brs H-5, H3-6 C-5, 8, 8a, CH3-6 
8 161.4, C --- --- --- 
8a 113.5, C --- --- --- 
9 189.2, CO --- --- --- 
9a ND --- --- --- 
10 181.6, CO --- --- --- 
10a 135.0, C --- --- --- 
CH3-6 21.5, CH3- 2.42, s H-5, 7 C-5, 6, 7 
OH-1, 8 --- 12.11, brs --- --- 
OH-3 --- --- --- --- 
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4.2.3.2. Questinol (VII) 
 
 
Figure 56. Structure of questinol (VII). 
 
Compound VII was also isolated as an orange solid (mp. 255-265 °C) and its 
molecular formula C16H12O6 was determined based on the (+)-HRESIMS m/z 301.0713 
[M+H]+ (calculated 301.0712), indicating eleven degrees of unsaturation. The 13C NMR, 
DEPT and HSQC spectra (Table 10) exhibited the signals of two conjugated ketone 
carbonyls (dC 186.1 and 182.5), two oxyquaternary sp2 (dC 163.6 and 161.8), five quaternary 
sp2 (dC 151.2, 136.8, 132.2, 115.2 and 112.0), one oxymethylene sp3 (dC 62.1) and one 
methoxyl (dC 56.2) groups. The 1H NMR spectra exhibited a broad singlet of one hydrogen-
bonded hydroxyl group at dC 13.40 and two pairs of doublets of the aromatic protons at dH 
7.57, d (J = 1.6 Hz)/ 7.20, d (J = 1.6 Hz) and at dH 7.18, d (J = 2.3 Hz)/ 6.80, d (J = 2.3 Hz), 
in addition to a singlet of the methoxy protons at dH 3.89 and a singlet of the oxymethylene 
protons at dH 4.58. That the two pairs of the aromatic protons belong to the two meta-
coupled benzene rings was substantiated by the COSY correlations (Table 10, Figure 57) 
from the proton at dH 7.57, d (J = 1.6 Hz) to the proton at dH 7.20, d (J = 1.6 Hz) as well as 
from the proton at dH 7.18, d (J = 2.3 Hz) to the proton at dH 6.80, d (J = 2.3 Hz). Moreover, 
the doublet at dH 6.80, d (J = 2.3 Hz) also showed cross peak to the methoxyl singlet at dH 
3.89, suggesting that the methoxyl group is in close proximity to this aromatic proton. On 
the other hand, both aromatic protons at dH 7.57, d (J = 1.6 Hz) and 7.20, d (J = 1.6 Hz) 
gave cross peaks to the oxymethylene protons at dH 4.58, s, suggesting that this 
oxymethylene group was flanked by these two aromatic protons. 
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Figure 57. Key COSY correlations ( ) of VII. 
 
 The HMBC spectrum (Table 10, Figure 58) exhibited cross peaks from the aromatic 
proton at dH 7.57, d (J = 1.6 Hz) to the carbons at dC 115.2 (C), 120.9 (CH) and the carbonyl 
carbon at dC 182.5, and from the aromatic proton at dH 7.20, d (J = 1.6 Hz) to the carbons at 
dC 115.2 (C), 115.8 (CH) and 161.8 (C), suggesting that this aromatic proton was next to 
the phenolic hydroxyl group. In turn, the singlet of the oxymethylene protons at dH 4.58, s 
gave cross peaks to the aromatic carbons at dC 115.8 (CH), 120.9 (CH) and the quaternary 
sp2 carbon at dC 151.2. Therefore, one of the 1,2,3,5-tetrasubstituted benzene ring was: 
 
 
Figure 58. The HMBC correlations ( ) of VII.  
 
 Moreover, the doublet at dH 7.18, d (J = 2.3 Hz) also gave HMBC cross peaks to the 
carbonyl carbon at dC 182.5, in addition to the aromatic carbons at dC 112.0 (C) and 105.1 
(CH), while the doublet at dH 6.80, d (J = 2.3 Hz) exhibited cross peaks with the aromatic 
carbons at dC 112.0 (C) and 108.0 (CH). As the methoxyl proton (dH 3.89, s) gave cross peak 
to the oxyquaternary carbon at dC 163.6, the methoxyl group is on this carbon. The chemical 
shift value of the aromatic proton at dH 6.80, d (J = 2.3 Hz) suggested also that it should be 
flanked by two oxygenated substituents, thus another substituent in this tetrasubstituted 
benzene ring should be a hydroxyl group (Figure 59). 
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Figure 59. The HMBC correlations ( ) of VII. 
 
 Since there is another carbonyl carbon at dC 186.1 in the structure, the two 
substituted benzene rings were connected by two conjugated ketone carbonyls presenting 
the anthraquinone scaffold similar to that of emodin (VI): 
 
 
Figure 60. Structure of questinol indicating 1H and 13C chemical shifts. 
 
Therefore, the structure of VII was identified as 3,8-dihydroxy-6-(hydroxymethyl)-1-
methoxy-9,10-anthraquinone or commonly known as questinol. 
 
Literature search revealed that questinol has been isolated from marine-derived 
fungus Eurotium amstelodami (Yang et al., 2014). 
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Table 10. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment 
for questinol (VII) 
Position dC, type dH, mult. (J in Hz) COSY HMBC 
1 163.6, C --- --- --- 
2 105.1, CH 6.80, d (2.3) H-4, OCH3 C-4, 9a 
3 161.8, C --- --- --- 
4 108.0, CH 7.18, d (2.3) H-2 C-2, 9a, 10 
4a 132.2, C --- --- --- 
5 115.8, CH 7.57, d (1.6) H-7, 11 C-7, 8a, 10 
6 151.2, C --- --- --- 
7 120.9, CH 7.20, d (1.6) H-5, 11 C-5, 8a, 8 
8 161.8, C --- --- --- 
8a 115.2, C --- --- --- 
9 186.1, CO --- --- --- 
9a 112.0, C --- --- --- 
10 182.5, CO --- --- --- 
10a 136.8, C --- --- --- 
11 62.1, CH2 4.58, s H-5, 7 C-5, 6, 7 
OCH3 56.2, CH3 3.89, s H-2 C-1 
OH-1 --- 13.40, brs --- --- 
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4.2.3.3. Citreorosein (VIII) 
 
 
Figure 61. Structure of citreorosein (VIII). 
 
Compound VIII was isolated as a yellow solid (mp. 287-289 °C). The 1H and 13C 
NMR spectra of VIII resembled those of VII, except for the absence of the methoxyl group. 
Moreover, the 1H and 13C NMR spectra exhibited two singlets at dH 12.05 and 12.03, 
characteristic of hydrogen-bonded phenolic hydroxyl groups. The 13C NMR, DEPT and 
HSQC spectra (Table 11) exhibited the signals of two conjugated ketone carbonyls (dC 
189.7 and 181.3), three oxyquaternary sp2 (dC 165.6, 164.5 and 161.5), five quaternary sp2 
(dC 152.9, 135.1, 132.9, 114.0 and 109.0), four methine sp2 (dC 120.8, 117.1, 108.8 and 
107.9) and one oxymethylene sp3 (dC 62.0), which is characteristic of hydroxymethyl 
anthraquinone. The 1H NMR (Table 11) exhibited, in addition to the two singlets of 
hydrogen-bonded hydroxyl groups at dH 12.05 and 12.03, two pairs of the meta-coupled 
aromatic protons at dH 7.60, d (J = 1.5 Hz)/ 7.21, d (J = 1.5 Hz) and dH 7.09, d (J = 2.4 Hz)/ 
6.56, d (J = 2.4 Hz), a singlet of the hydroxymethyl group at dH 4.59 and a broad singlet of 
a hydroxyl group at dH 5.58.  
 
The COSY spectrum (Table 11, Figure 62) exhibited, on the one hand, cross peaks 
from the doublet at dH 7.60, d (J = 1.5 Hz) to the doublet at dH 7.21, d (J = 1.5 Hz), and the 
singlet at dH 4.59, as well as from the doublet at 7.21, d (J = 1.5 Hz) to the doublet at dH 
7.60, d (J = 1.5 Hz) and the singlet at dH 4.59, on the other hand, from the doublet at dH 7.09, 
d (J = 2.4 Hz) to the doublet at dH 6.56, d (J = 2.4 Hz). These correlations not only confirmed 
the presence of two 1,2,3,5-tetrasubstituted benzene rings but also the position of the 
hydroxymethyl group between the meta-coupled protons in one of the benzene rings: 
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Figure 62. Key COSY correlations ( ) of VIII. 
 
The HMBC spectrum (Table 11) exhibited correlations of both aromatic protons at 
dH 7.09, d (J = 2.4 Hz) and dH 7.60, d (J = 1.5 Hz) to the carbonyl carbon at dC 181.3 whereas 
the singlets of the hydrogen-bonded hydroxyl protons at dH 12.05 and 12.03 gave cross 
peaks, respectively, to the oxyquaternary carbons at dC 164.5 and 161.5. Another carbonyl 
group (dC 189.7) was hydrogen-bonded with these two phenolic hydroxyl groups since it has 
a much higher resonance (dC 189.7). Taken together these data, it was possible to identify 
VIII as 1,3,8-trihydroxy-6-(hydroxymethyl)anthra-9,10-quinone. The HMBC correlations 
from the doublet at dH 7.09, d (J = 2.4 Hz) to the carbon at dC 109.0, from dH 6.56, d (J = 2.4 
Hz) to the carbons at dC 109.0, 164.5 and 165.6 allow an assignment for C-3 and C-9a. 
Similarly, the HMBC correlations from the doublet at dH 7.60, d (J = 1.5 Hz) to the carbons 
at dC 62.0, 114.0, 120.8 and 181.3, and from the doublet at dH 7.21, d (J = 1.5 Hz) to the 
carbons at dC 114.0, 117.1 and 161.5 confirmed the assignment for C-8a, C-5 and C-8. 
 
 
Figure 63. Structure of citreorosein indicating 1H and 13C chemical shifts. 
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Literature search revealed that VIII, also known as citreorosein, has been isolated 
from Ascomycete, Zopfiella longicaudata (Fujimoto et al., 2004) and from a gorgonian coral-
associated fungus Penicillium sp. (Bao et al., 2013). 
 
Table 11. 1H and 13C NMR (DMSO, 500.13 MHz and 125.4 MHz) and HMBC assignment 
for citreorosein (VIII). 
Position dC, type dH, mult. (J in Hz) COSY HMBC 
1 164.5, C --- --- --- 
2 107.9, CH 6.56, d (2.4) H-4 C-1, 3, 4, 9a 
3 165.6, C --- --- --- 
4 108.8, CH 7.09, d (2.4) H-2 C-9a, 10 
4a 132.9, C --- --- --- 
5 117.1, CH 7.60, d (1.5) H-7, 11 C-7, 8a, 10, 11 
6 152.9, C --- --- --- 
7 120.8, CH 7.21, d (1.5) H-5, 11 C-5, 8, 8a 
8 161.5, C --- --- --- 
8a 114.0, C --- --- --- 
9 189.7, CO --- --- --- 
9a 109.0, C --- --- --- 
10 181.3, CO --- --- --- 
10a 135.1, C --- --- --- 
11 62.0, CH2 4.59, s --- C-5, 6, 7 
OH-1 --- 12.05, s --- C-1, 2 
OH-8 --- 12.03, s --- C-7, 8, 8a 
OH-11 --- 5.58, brs --- --- 
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4.2.3.4. Fallacinol (IX) 
 
 
Figure 64. Structure of fallacinol (IX) 
 
 Compound IX was also isolated as a yellowish orange crystals (mp. 205-208 °C). 
The 1H and 13C NMR spectra of IX resembled those of citreorosein (VIII). The 1H NMR and 
COSY spectra exhibited the signals of two pairs of meta-coupled aromatic protons at dH 
6.87, d (J = 2.3 Hz)/ 7.24, d (J = 2.3 Hz) and dH 7.23, d (J = 1.5 Hz)/ 7.61, d (J = 1.5 Hz), 
the signals of the hydroxymethylene group at dH 4.59, d (J = 5.6 Hz) and dH 5.53, t (J = 5.9 
Hz), in addition to the singlets of the hydrogen-bonded hydroxyl at dH 13.30 and the methoxyl 
group at dH 3.92 (Table 12). The 13C NMR spectrum (Table 12) exhibited sixteen carbon 
signals which can be categorized, through DEPTs and HSQC spectra, into two conjugated 
ketone carbonyls (dC 182.3 and 186.4), eight quaternary sp2 (dC 164.5, 163.5, 161.7, 151.4, 
136.9, 132.1, 115.1 and 112.7), four methine sp2 (dC 120.9, 115.8, 107.0 and 105.0), one 
oxymethylene sp2 (dC 62.0), and one methyl (dC 56.4) groups. The COSY spectrum (Table 
12, Figure 65) exhibited correlations from the oxymethylene protons (H2-11) at dH 4.59, d 
(J = 5.6 Hz) to the meta-coupled aromatic protons at dH 7.23, d, J = 1.5 Hz (H-7)/ 7.61, d, J 
= 1.5 Hz (H-5) as well as from the methoxyl proton at dH 3.92 to the meta-coupled aromatic 
protons at dH 6.87, d, J = 2.3 Hz (H-2)/ 7.24, d, J = 2.3 Hz (H-4). Therefore, the structure of 
IX consisted of two 1,2,3,5-tetrasubstituted benzene rings: 
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Figure 65. Key COSY correlations ( ) of compound IX. 
 
Since the HMBC spectrum (Table 12, Figure 66) exhibited correlations of the 
aromatic protons at dH 7.24, d, (J = 2.3 Hz, H-4) and 7.61, d (J = 1.5 Hz, H-5) to the carbonyl 
at dC 182.3, this carbonyl group was placed on C-10. Moreover, the singlet of the hydrogen-
bonded proton (dH 13.30) gave cross peaks to the carbons at dC 161.7 (C-8), 120.9 (C-7) 
and 115.1 (C-8a), while the singlet of the methoxyl protons showed cross peaks to the 
carbon at dC 163.5, the hydroxyl and the methoxyl groups were placed on C-8 and C-3, 
respectively. Moreover, as the doublet of the oxymethylene protons at dH 4.59, d, J = 5.6 Hz 
(H2-11) gave the HMBC cross peak to the carbon at dC 151.4, this carbon was assigned to 
C-6. On the other hand, both of the aromatic protons at dH 6.87, d, (J = 2.3 Hz, H-2)/ 7.24, 
d, (J = 2.3 Hz, H-4) exhibited cross peaks to the carbon at dC 112.7, this carbon was 
assigned to C-9a. Taken together these correlations, the partial structure of compound IX 
is: 
 
 
Figure 66. The HMBC correlations ( ) of IX. 
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 Since there is another conjugated carbonyl with hydrogen-bonding (dC 186.4), this 
carbonyl was placed on C-9, completing the structure of 1,8-dihydroxy-2-methoxy-6-
(hydroxymethyl)-9,10-anthraquinone (IX). 
 
 
Figure 67. Structure of fallacinol indicating 1H and 13C chemical shifts. 
 
 Literature search revealed that IX, named fallacinol, has been previously isolated 
from lichenized fungi Xanthoria fallax (Murakami, 1956), Xanthoria parientina (Piattelli and 
de Nicola, 1968) and Caloplaca schaereri (Manojlovic et al., 2002). Later on, fallacinol has 
been discovered from marine-derived fungi Aspergillus variecolor (Wang et al., 2007). 
 
Table 12. 1H and 13C NMR (DMSO, 500.13 MHz and 125.4 MHz) and HMBC assignment 
for fallacinol (IX). 
Position dC, type dH, mult. (J in Hz) COSY HMBC 
1 164.5, C --- --- --- 
2 105.0, CH 6.87, d (2.3) H-4, OMe C-1, 4, 9a 
3 163.5, C --- --- --- 
4 107.0, CH 7.24, d (2.3) H-2, OMe C-2, 9a, 10 
4a 136.9, C --- --- --- 
5 115.8, CH 7.61, d (1.5) H-7, 11 C-7, 8a, 10 
6 151.4, C --- --- --- 
7 120.9, CH 7.23, d (1.5) H-5, 11 C-5, 8a 
8 161.7, C --- --- --- 
8a 115.1, C --- --- --- 
9 186.4, CO --- --- --- 
9a 112.7, C --- --- --- 
10 182.3, CO --- --- --- 
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Position dC, type dH, mult. (J in Hz) COSY HMBC 
10a 132.1, C --- --- --- 
11 62.0, CH2 4.59, d (5.6) H-5, 7 C-5, 6, 7 
OCH3-3 56.4, CH3 3.92, s H-2, 4 C-3 
OH-8 --- 13.30, s --- C-7, 8, 8a 
OH-11 --- 5.53, t (5.9) H-11 --- 
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4.2.3.5. 1,3,6,8-tetrahydroxy-9,10-anthraquinone = Rheoemodin (X) 
 
 
Figure 68. Structure of rheoemodin (X). 
 
 Compound X was isolated as a brown solid (mp. 164-167 °C). The 1H and 13C NMR 
spectra of X resemble those of emodin (VI), except for the absence of the methyl group. 
Additionally, the 13C NMR, DEPT and HSQC spectra (Table 13) exhibited the signals of two 
conjugated ketone carbonyls (dC 189.2 and 180.9), four oxyquarternary sp2 (dC 166.3, 165.6, 
164.8 and 161.1), four quaternary sp2 (dC 135.1, 133.5, 118.3 and 109.2), four methine sp2 
(dC 124.2, 118.9, 109.3 and 108.1), respectively. The 1H NMR spectrum (Table 13) exhibited 
two pairs of doublets of aromatic protons at dH 8.08, d (J = 1.6 Hz)/ 7.71, d (J = 1.6 Hz) and 
at dH 7.13, d (J = 2.3 Hz)/ 6.60, d (J = 2.3 Hz), in addition to two broad singlets of hydrogen-
bonded hydroxyl groups at dH 12.03. That the two pairs of the aromatic protons belong to 
the two meta-coupled benzene rings was substantiated by COSY correlations (Table 13, 
Figure 69) from the proton at dH 8.08, d (J = 1.6 Hz, H-5) to the proton at dH 7.71, d (J = 1.6 
Hz, H-7), as well as from the proton at dH 7.13, d (J = 2.3 Hz, H-4) to the proton at dH 6.60, 
d (J = 2.3 Hz, H-2). Therefore, the structure of X consisted of two 1,2,3,5-tetrasubstituted 
benzene rings. 
 
 
Figure 69. Key COSY correlations ( ) of X. 
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 The HMBC spectrum (Table 13, Figure 70) showed cross peaks from the aromatic 
proton at dH 8.08, d (J = 1.6 Hz, H-5) to the ketone carbonyl group (dC 180.9, C-10), aromatic 
carbons at dC 118.3 (C-8a) and 124.2 (CH-7), as well as from the aromatic proton at dH 7.71, 
d (J = 1.6 Hz, H-7) to the aromatic carbons at dC 165.6 (C-6), 161.1 (C-8) and 118.3 (C-8a), 
suggesting that this aromatic proton was next to the phenolic hydroxyl group. On the other 
hand, the HMBC spectrum also showed cross peaks from the aromatic proton at dH 7.13, d 
(J = 2.3 Hz, H-4) to the ketone carbonyl (dC 180.9, C-10) and the aromatic carbon at dC 
109.2 (C-9a), as well as from the aromatic proton at dH 6.60, d (J = 2.3 Hz, H-2) to the 
aromatic carbons at dC 166.3 (C-1) and dC 109.3 (CH-4). The chemical shift value of the 
aromatic protons at dH 6.60 (C-2) and dH 7.71 (C-7) suggested also that they should be 
flanked by two oxygenated substituents. Therefore, these substituents should be the 
hydroxyl groups.  
 
 
Figure 70. The HMBC correlations ( ) of X. 
 
Moreover, HMBC spectrum also exhibited correlations of both aromatic protons at 
dH 8.08, d (J = 1.6 Hz, H-5) and dH 7.13, d (J = 2.3 Hz, H-4) to the carbonyl carbon at dC 
180.9 (C-10). Another carbonyl group (dC 189.2, C-9) was hydrogen-bonded with two 
phenolic hydroxyl groups since it has a very high resonance (dC 189.2, C-9). Thus, the two 
substituted benzene rings were connected by two conjugated ketone carbonyls rendering 
the anthraquinone scaffold similar to emodin (VI). 
 
OH
H
H HO
H
OH
OH
7.13, d (2.3)
109.3
6.60, d (2.3)
108.1
164.8
109.2
180.9
118.3
118.9
8.08, d (1.6)
7.71, d (1.6) 161.1
124.2
165.6
HO
166.3
		 90	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
 
Figure 71. Structure of rheoemodin (X) indicating 1H and 13C chemical shifts. 
 
 Therefore, the structure of X is identified as 1,3,6,8-tetrahydroxy-9,10-
anthraquinone or commonly known as rheoemodin. 
Literature search revealed that rheoemodin (X) has been isolated from Geomithia 
species (Stodůlková et al., 2009) and also from the endophytic fungus Nigrospora sp. 
(Huang et al., 2016). 
 
Table 13. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment for 
rheoemodin (X) 
Position dC, type dH, mult. (J in Hz) COSY HMBC 
1 166.3, C --- --- --- 
2 108.1, CH 6.60, d (2.3) H-4 C-1, 4, 8a 
3 164.8, C --- --- --- 
4 109.3, CH 7.13, d (2.3) H-2 C-9a, 10 
4a 133.5, C --- --- --- 
5 118.9, CH 8.08, d (1.6) H-7 C-7, 8a, 10 
6 165.6, C --- --- --- 
7 124.2, CH 7.71, d (1.6) H-5 C-6, 8, 8a 
8 161.1, C --- --- --- 
8a 118.3, C --- --- --- 
9 189.2, CO --- --- --- 
9a 109.2, C --- --- --- 
10 180.9, CO --- --- --- 
10a 135.1, C --- --- --- 
OH-1 --- 12.03, brs --- --- 
OH-8 --- 12.03, brs --- --- 
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OHHO
OH
166.3
H
H
H
H
6.60, d (2.3)
108.1
164.8
109.3
7.13, d (2.3)
180.9118.9
8.08 d (1.6)
135.1
118.3 109.2
133.5
189.2161.1
12.03, brs 12.03, brs
7.71, d (1.6)
124.2
165.6
		 91	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
4.2.4. Structure Elucidation of Bis - Xanthone and Bis - Anthraquinone 
 
4.2.4.1. Secalonic acid A (XI) 
 
Compound XI was also isolated as yellow crystal (mp. 268-270 °C). The 13C NMR 
spectrum (Table 14) exhibited sixteen carbon signals which were categorized, through 
DEPT and HSQC spectra (Table 14), as one conjugated ketone carbonyl (dC 186.5), one 
ketone or enolic (dC 178.2), one ester carbonyl (dC 170.0), two oxyquaternary sp2 (dC 158.9 
and 158.5), three quaternary sp2 (dC 117.3, 106.3 and 101.7), two methine sp2 (dC 140.2 and 
107.5), one oxyquaternary sp3 (dC 85.2), one oxymethine sp3 (dC 75.2), one methine sp3 (dC 
29.9), one methylene sp3 (dC 35.8), one methyl (dC 17.7) and one methoxyl (dC 52.9) groups. 
The 1H NMR spectrum (Table 14) exhibited two ortho-coupled aromatic protons at dH 7.46, 
d, (J = 8.5 Hz) and 6.63, d, (J = 8.5 Hz), a broad singlet of one hydrogen-bonded phenolic 
hydroxyl at dH 11.62, one broad signal of one enolic hydroxyl at dH 13.70, one double doublet 
of the hydroxyl at dH 6.04, dd, (J = 5.7, 2.5 Hz), one double doublet at dH 3.82, dd, (J = 10.0, 
5.7 Hz), three multiplets at dH 2.50 (1H), 2.67 (1H), 2.30 (1H), a doublet of one methyl at dH 
1.04, d, (J = 6.0 Hz) and a methoxyl singlet at dH 3.62. That the ortho-coupled aromatic 
protons belonged to the 2,3,5-trisubstituted phenol was supported by the HMBC 
correlations from the hydrogen-bonded phenolic hydroxyl group at dH 11.62 to the 
oxyquaternary sp2 carbon at dC 158.5 (C-1) and the quaternary sp2 carbons at dC 117.3 (C-
2) and 106.3 (C-9a), from the doublet at dH 7.46, d, (J = 8.5 Hz) to C-1, C-2 and another 
oxyquaternary sp2 carbon at dC 158.9, the latter was assigned to C-4a, as well as from the 
doublet at dH 6.63, d, (J = 8.5 Hz) to C-2, C-4a and C-9a (Figure 72). 
 
 
Figure 72. The HMBC correlations ( ) of XI. 
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 The COSY spectrum (Table 14, Figure 73) exhibited cross peaks from the double 
doublet of the methine proton at dH 3.82 (J = 10.0, 5.7 Hz, H-5) to the double doublet of the 
hydroxyl proton at dH 6.04 (J = 5.7, 2.5 Hz) and a multiplet of another methine proton at dH 
2.30 (H-6), while the latter also showed cross peaks to the methyl doublet at dH 1.04 (J = 
6.0 Hz) as well as the multiplets at dH 2.50 and 2.67 (H2-7), suggesting the presence of the 
following coupling system: 
 
 
Figure 73. Key COSY correlations ( ) of XI. 
 
 This coupling system was supported by HMBC correlations (Table 14, Figure 74) 
from the double doublet of the hydroxyl proton at dH 6.04, dd, (J = 5.7, 2.5 Hz) to the 
oxymethine sp3 at dC 75.2 (C-5) and the methine sp3 carbon at dC 29.9 (C-6) as well as from 
the double doublet of the methine proton at dH 3.82, dd, (J = 10.0, 5.7 Hz, H-5) to the methyl 
carbon at dC 17.7 (C-11) and the methine carbon at dC 29.9 (C-6). Furthermore, the methine 
proton at dH 3.82, dd, (J = 10.0, 5.7 Hz, H-5) showed also HMBC cross peaks to the 
oxyquaternary sp3 carbon at dC 85.2 (C-10a) and the ester carbonyl at dC 170.0 (C-12), 
suggesting that C-10a is connected to the ester group. Since the methoxyl singlet at dH 3.62 
(dC 52.9) showed also a cross peak to this ester carbonyl group, it was clear that one of the 
substituents on the oxyquaternary sp3 carbon at dC 85.2 was an acetyl group. Moreover, the 
HMBC spectrum also exhibited cross peaks from the multiplets at dH 2.50 and 2.67 to the 
enolic carbon at dC 178.2 and the quaternary sp2 carbon at dC 101.7, suggesting the 
presence of the following moiety: 
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Figure 74. The HMBC correlations ( ) of XI.  
 
 Taking together the two-partial structures deduced from the NMR data, the structure 
of XI was purposed as methyl 1,4-dihydroxy-3-methyl-9-oxo-2,3,4,9-tetrahydro-4aH-
xanthene-4a-carboxylate: 
 
 
Figure 75. The partial structure of XI indicating the 1H and 13C chemical shift values. 
 
 However, this structure lacks a substituent on the carbon at dC 117.3 of the phenolic 
moiety. This structure also accounts for C16H15O7. Since the (+)-HRESIMS of XI gave the 
m/z 639.1714 for its [M+H]+ (calculated for C32H31O14, 639.1714) its molecular formula was 
established as C32H30O14, which is double of the proposed structure established by the NMR 
data. Therefore, XI must correspond to a dimer of the proposed structure, linked through its 
carbon at dC 117.3, i.e.: 
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Figure 76. The structure of XI. 
 
 This hypothesis was also supported by the HMBC correlation from H-3 (dH 7.46, d, 
J = 8.5 Hz) to C-2’ (dC 117.3). This structure also accounts for the molecular formula 
C32H30O14 which corresponds to eighteen degrees of unsaturation. 
 
 The structure of XI has six stereogenic carbons in total (three for each monomer), 
i.e. C-5/C-5’, C-6/C-6’ and C-10a/C-10’a. Since XI was obtained as a suitable crystal, X-ray 
analysis was performed. The Ortep view (Figure 77) not only confirms the structure of XI 
but also determines the absolute configurations of C-5/C-5’, C-6/C-6’ and C-10a/C-10’a, 
respectively as C-5S/C-5’S, C-6R/C-6’R, and C-10aS/C-10’aS. 
 
 
Figure 77. Ortep view of XI. 
 
Thus, the complete structure of XI is proposed to be: 
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Figure 78. The complete structure of XI. 
 
 Literature search revealed that the structure of XI corresponds to secalonic acid A, 
a secondary metaboilite isolated from various fungi including Aspergillus ochraceus 
(Yamazaki et al., 1971), Pyrenochaeta terrestris (Kurobane et al., 1979) and 
Pseudoparmelia sphaerospora (Honda et al., 1995). 
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Table 14. 1H and 13C NMR (DMSO, 300.13 MHz and 75.4 MHz) and HMBC assignment for 
secalonic acid A (XI). 
Position dC, type dH, mult. (J in Hz) COSY HMBC 
1 (1’) 158.5, C --- --- --- 
2 (2’) 117.3, C --- --- --- 
3 (3') 140.2, CH 7.46, d (8.5) H-4 (4’) C-1 (1’), 4a (4’a), 
2 (2’) 
4 (4’) 107.5, CH 6.63, d (8.5) H-3 (3’) C-2 (2’), 4a (4’a), 
9a (9’a) 
4a (4’a) 158.9, C --- --- --- 
5 (5’) 75.2, CH 3.82, dd (10.0, 5.7) OH-5 (5’), 6 
(6’) 
C-6 (6’), 10a 
(10’a), 11 (11’), 12 
(12’) 
6 (6’) 29.9, CH 2.30, m H-5 (5’), 7 (7’), 
11 (11’) 
--- 
7 (7’) 35.8, CH2 2.50, m 
2.67, m 
H-6(6’) 
H-6(6’) 
C-8 (8’), 8a (8’a) 
C-8 (8’), 8a (8’a) 
8 (8’) 178.2, CO --- --- --- 
8a (8’a) 101.7, C --- --- --- 
9 (9’) 186.5, CO --- --- --- 
9a (9’a) 106.3, C --- --- --- 
10a (10’a) 85.2, C --- --- --- 
11 (11’) 17.7, CH3 1.04, d (6.0) H-6 (6’) --- 
12 (12’) 170.0, CO --- --- --- 
OCH3 52.9, CH3 3.62, s --- C-12 (12’) 
OH-5 (5’) --- 6.04, dd (5.7, 2.5) H-5 (5’) C-5 (5’), 6 (6’) 
OH-1 (1’) --- 11.62, brs --- C-1 (1’), 2 (2’), 9a 
(9’a) 
OH-8 (8’) --- 13.70, br --- --- 
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4.2.4.2. Bis-(7-methyl-1,4,5-trihydroxy-anthracene-9,10-dione) (XII) 
 
 
Figure 79. Structure of XII.  
 
 Compound XII was isolated as a reddish orange solid (mp. 258-260 °C). The IR 
spectrum showed absorption bands for hydroxyl (3463 cm-1), conjugated ketone carbonyl 
(1622 cm-1) and aromatic (1550 cm-1) groups. 
 
The 13C NMR spectrum (Table 15) exhibited fifteen carbon signals which, in 
conjunction with DEPTs and HSQC spectra, can be categorized as two conjugated ketone 
carbonyls (dC 189.6 and 182.1), nine quaternary sp2 (dC 164.4, 164.3, 161.1, 148.2, 133.2, 
131.3, 123.5, 113.1 and 108.9), three methine sp2 (dC 123.6, 120.5 and 107.2) and one 
tertiary methyl (dC 21.5) groups. The 1H NMR spectrum (Table 15) showed one singlet at dH 
6.73 and two double doublets at dH 7.15, dd (J = 1.0, 0.5 Hz) and 7.28, dd (J = 1.0, 0.5 Hz) 
of the aromatic protons and one singlet of the tertiary methyl (dH 2.33), in addition to two 
singlets of the hydrogen bonded hydroxyl groups at dH 12.04 and dH 12.79. 
 
The 1H and 13C NMR features suggested that compound XII was a polyhydroxy- 
methyl anthraquinone. That one of the benzene rings of XII was a 3-hydroxy-5-methyl-
1,2,3,5-tetrasubstituted was supported by the COSY correlations from the aromatic protons 
at dH 7.15 (J = 1.0, 0.5 Hz, H-6) and 7.28 (J = 1.0, 0.5 Hz, H-8) to the methyl protons at dH 
2.33 as well as by the HMBC correlations from H-6 to C-8 (dC 120.5), C-5 (dC 161.1), C-10a 
(dC 113.1) and CH3-7 (dC 21.5), from H-8 to C-6 (dC 123.6), C-10a and CH3-7, as well as from 
OH-5 (dH 12.04, s) to C-5 (dC 161.1), C-6 and C-10a (Table 15, Figure 80). Since the methyl 
protons showed HMBC correlation with the carbon at dC 148.2, it was assigned to C-7.  
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Figure 80. Key COSY ( ) and HMBC ( ) correlations of XII. 
 
On the other hand, another benzene ring of XII was 3,6-dihydroxy-1,2,3,4,6-
substituted since the HMBC spectrum (Table 15, Figure 81) exhibited correlations from the 
aromatic proton singlet at dH 6.73 (H-3) to C-1 (dC 164.3), C-4 (dC 164.4), C-4a (dC 108.9) as 
well as from the hydroxyl singlet at dH 12.79 (OH-4) to C-3 (dC 107.2), C-4 (dC 164.4) and C-
4a (dC 108.9). 
 
 
Figure 81. HMBC ( ) correlations of compound XII. 
 
 Moreover, the HMBC spectrum (Table 15) also exhibited a cross peak from H-8 to 
the carbonyl carbon at dC 182.1, the latter was assigned to C-9. Since, there was no cross 
peak from H-3 to either of the carbonyl carbons, the carbonyl carbon at dC 189.6 was 
assigned to C-10. The higher chemical shift value of C-10 than that of C-9 was justified by 
its hydrogen bonding with both OH-4 and OH-5. By comparing the 13C NMR spectrum of XII 
to those of other anthraquinones isolated from this fungus, i.e. emodin (VI), citreorosein 
(VIII), fallacinol (IX) and rheoemodin (X), the carbons at dC 131.3 and dC 133.2 were 
assigned to C-8a and C-9a, respectively. Therefore, the structure of XII was tentatively 
established as 7-methyl-1,4,5-trihydroxy-9,10-anthraquinone (Figure 82). 
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Figure 82. Partial structure of 7-methyl-1,4,5-trihydroxy-9,10-anthraquinone. 
 
 However, this structure (C15H9O5) was not complete since there was no substituent 
on C-2 (dC 123.5) to be accounted for. Since the (+)-HRESIMS of XII gave the [M+H]+ peak 
at m/z 539.0942 [M+H]+, corresponding to C30H19O10 (calculated 539.0978), the molecular 
formula of XII was C30H18O10 (twenty two degrees of unsaturation). Therefore, the structure 
of XII was a dimer of 7-methyl-1,4,5-trihydroxy-9,10-anthraquinone. 
 
 
Figure 83. HMBC correlations of the dimer of 7-methyl-1,4,5-trihydroxy-9,10-
anthraquinone. 
 
 This structure was also supported by the HMBC correlation (Figure 83) from H-2 to 
the quaternary sp2 carbon at dC 123.5 (C-2’). Therefore, the structure of XII was established 
as 2, 2’-bis-(7-methyl-1,4,5-trihydroxy-anthracene-9,10-dione). 
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 Literature search revealed that Tan et al. (2008) have reported isolation of the 
structurally similar bis-anthraquinone, named 2240A, from an unidentified endophytic 
fungus (strain no 2240), isolated from the estuarine mangrove from the South China Sea 
Coast. The structure of 2240A is also a dimer of 7-methyl-1,4,5-trihydroxy-9,10-
anthraquinone, however, the two anthraquinone monomers are linked between C-3 and C-
3’ (i.e. C-1/1’ for the numbering used by Tan et al. (2008)) instead of C-2 and C-2’ as in XII. 
Surprisingly, the 1H and 13C NMR chemical shift values reported for 2240A by Tan et al. 
(2008) were very similar to those of XII. Although the structures of XII and 2240A cannot be 
distinguished by HMBC correlations, careful analysis of the 1H and 13C NMR data of 2240A 
revealed that Tan et al. (2008) assigned the chemical shift values to some of the carbons 
differently from what we assigned for XII. Tan et al. (2008) assigned the carbon signal at dC 
108.7 to C-9a/9’a (i.e. C-14/14’ for the numbering used by Tan et al. (2008)) instead of C-
4a/4’a (i.e. C-13/13’ for the numbering used by Tan et al. (2008)) and the carbon signal at 
dC 131.8 to C-4a/4’a (i.e. C-13/C-13’ for the numbering use by Tan et al. (2008)) instead of 
C-9a/9’a (i.e. C-13/C-13’ for the numbering used by Tan et al. (2008)). This assignment 
seems to be incorrect since the chemical values of C-4a and C-10a of a series of 
anthraquinones with the hydroxyl groups on C-4 and C-5 isolated from this extract, i.e. 
emodin (VI), citreorosein (VIII), fallacinol (IX) and rheoemodin (X), are dC 108 and 115 ppm, 
which is far from dC 133 ppm proposed by Tan et al. (2008). Consequently, we are 
convinced that the structure proposed for 2240A is not correct (Figure 84).  
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Figure 84. Comparison of the 1H and 13C NMR data of XII (A) and 2240A (B) (Tan et al. 
2008). 
 
Interestingly, Tan et al. (2008) reported 2240A as dextrorotatory, displaying [α]20D 
+62.50 (c 0.08, dioxin). On the contrary, XII is levorotatory having [α]20D -40 (c 0.05, dioxin) 
and -100 (c 0.05, MeOH), respectively. Since XII can be considered as a bridged biphenyl, 
it can have a phenomenon of atropisomerism due to a restricted rotation of the phenyl rings 
around the C-2/C-2’ bond. Therefore, XII and 2240A, previously reported by Tan et al. 
(2008) are different and could probably be atropisomers (Figure 85). 
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Figure 85. Atropisomers of XII, (P): right-handed helix, (M): left-handed helix. 
 
The structure of XII can be viewed as a dimer of helminthosporin, the anthraquinone 
previously isolated from the subterranean stems of Aloe saponaria Haw.(Yagi et al., 1977) 
and also from the roots of Berchemia floribunda (Wei et al., 2008). However, to the best of 
our knowledge, there is no report so far on the isolation of bis-anthraquinone with this 
structure. 
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Table 15.  1H and 13C NMR (DMSO, 500.13 MHz and 125.4 MHz) and HMBC assignment 
for 2, 2’-bis-(7-methyl-1,4,5-trihydroxy-anthracene-9,10-dione) (XII). 
Position dC, type dH, mult. (J in Hz) COSY HMBC 
1 (1’) 164.3, C --- --- --- 
2 (2’) 123.5, C --- --- --- 
3 (3’) 107.2, CH 6.73, s --- C-1 (1’), 4 (4’), 2 
(2’), 4a (4’a) 
4 (4’) 164.4, C --- --- --- 
4a (4’a) 108.9, C --- --- --- 
5 (5’) 161.1, C --- --- --- 
6 (6’) 123.6, CH 7.15, dd (1.0, 0.5) H-8 (8’), Me-7 (7’) C-5 (5’), 7 (7’), 8 
(8’), 10a (10’a) 
7 (7’) 148.2, C --- --- --- 
8 (8’) 120.5, CH 7.28, dd (1.0, 0.5) H-6 (6’), Me-7 (7’) C-6 (6’), 7 (7’), 9 
(9’), 10a (10’a) 
8a (8’a) 131.3, C* --- --- --- 
9 (9’) 182.1, CO --- --- --- 
9a (9’a) 133.2, C* --- --- --- 
10 (10’) 189.6, CO --- --- --- 
10a (10’a) 113.1, C --- --- --- 
CH3-7 (7’) 21.5, CH3 2.33, s H-6 (6’), 8 (8’) C-6 (6’), 7 (7’), 8 
(8’) 
OH-4 (4’) --- 12.79, s --- C-3 (3’), 4 (4’), 
4a (4’a) 
OH-5 (5’) --- 12.04, s --- C-5 (5’), 6 (6’), 
10a (10’a) 
*can be interchanged. 
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4.3. Biological Activity Tests 
 
4.3.1. Anti-obesity activity on the zebrafish Nile red assay 
 
 Emodin (VI), questinol (VII), citreorosein (VIII), fallacinol (IX), rheoemodin (X) and 
secalonic acid A (XI) were tested for their anti-obesity activity on the zebrafish Nile red 
assay using resveratrol as a positive control as described in Jones et al. (Jones et al., 2008). 
The result showed that only the anthraquinones questinol (VII) and citreorosein (VIII) 
reduced > 60% and > 90% of the stained lipids with the IC50 values of 0.95 and 0.17 µM, 
respectively. The positive control resveratrol (REV) had an IC50 value of 0.6 µM (Figure 86). 
 
Interestingly, emodin (VI) and secalonic acid A (XI) caused toxicity (death) for all 
exposed zebrafish larvae after 24h while fallacinol (IX) and rheoemodin (X) did not have 
any significant effects (Figure 87). 
 
 
Figure 86. Anti-obesity activity of compounds VI-XI in the zebrafish larvae Nile red assay. 
The solvent control had 0.1% DMSO and the positive control received 50 µM resveratrol 
(REV). Values are presented as mean fluorescent intensity (MFI) relative to the DMSO 
group, and are derived from 10-12 individual larvae per treatment group. Statistical 
differences to the solvent control are indicated with asterisks, *** = p < 0.001. 
 
 It is interesting to observe that questinol (VII), citreorosein (VIII) and fallacinol (IX) 
are structurally similar, all having a hydroxymethyl group on C-6 and a hydroxyl group on 
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C-8. Replacing the hydroxyl group on C-1 by a methoxyl group, as in questinol (VII), 
diminishes the activity whereas replacing the hydroxyl group on C-3 with a methoxyl group, 
as in fallacinol (IX), completely removes the anti-obesity activity. Therefore, it seems that 
the hydroxymethyl group on C-6 and the hydroxyl groups on C-3 and C-8 are necessary for 
the anti-obesity activity of the polyhydroxy anthraquinones. 
 
 
Figure 87. Representative images of the zebrafish Nile red assay. The upper images show 
the overlay of the fluorescence and phase contrast; the lower images show the mean 
fluorescence intensity (MFI) given as black and white picture. DMSO, solvent control 0.1%.  
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5. Conclusion 
 
 This study describes the isolation, purification, structure elucidation and anti-obesity 
activity evaluation of the secondary metabolites produced by the fungus Talaromyces 
stipitatus KUFA 0207, isolated from the marine sponge Stylissa flabelliformis which was 
collected from the Gulf of Thailand. 
 
Isolated from the crude ethyl acetate extract of the culture of this fungus are a new 
ergosterol derivative, talarosterone (V), a new bis-anthraquinone derivative, bis-(7-methyl-
1,4,5-trihydroxy-anthracene-9,10-dione) (XII), in addition to ten known compounds 
including palmitic acid (I), ergosterol-5,8-endoperoxide (II), ergosta-4,6,8 (14),22-tetraen-3-
one (III), cyathisterone (IV) and the previous reported anthraquinones include emodin (VI), 
questinol (VII), citreorosein (VIII), fallacinol (IX), rheoemodin (X) as well as secalonic acid 
A (XI). 
 
Emodin (VI) has been previously reported from the fungus Talaromyces stipitatus 
chemotype II (Frisvad et al., 1990), while the other obtained metabolites have never been 
reported from this fungal species. Interestingly, talarosterone (V) and the bis-anthraquinone 
derivative (XII) are new compounds whose structure and stereochemistry were established 
by 1D and 2D NMR techniques, including 1H, 13C NMR, DEPT, COSY, HSQC, and HMBC. 
Moreover, talarosterone (V) was also determined the stereochemistry by X-ray 
crystallographic analysis. 
 
Compound VI–XI were tested for their anti-obesity activity by the zebrafish Nile red 
assay using resveratrol as a positive control. Citreorosein (VIII) exhibited a strong anti-
obesity activity (IC50 = 0.17 µM) while questinol (IX) showed moderate activity (IC50 = 0.95 
µM) in this test system. Analysis of the structures of the anthraquinones tasted revealed 
that the hydroxymethyl group on C-6 and the hydroxyl groups on C-3 and C-8 are required 
for the anti-obesity activity. The results obtained from this study suggested that marine-
derived fungi of the genus Talaromyces can be a promising source of compounds with 
potential anti-obesity activity. 
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6. Appendix 
 
6.1 NMR Spectra of Isolated Compounds 
 
6.1.1 NMR Spectrum of Palmitic acid (I) 
 
 1H NMR spectrum (500.13 MHz) 
 
 
 13C NMR spectrum (125.4 MHz) 
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6.1.2 NMR Spectrum of Ergosterol-5,8-endoperoxide (II) 
 
 1H NMR spectrum (300.13 MHz) 
 
 
 13C NMR spectrum (75.4 MHz) 
 
 
 
		
	
111	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
6.1.3 NMR Spectrum of Ergosta-4,6,8(14),22-tetraen-3-one (III) 
 
 1H NMR spectrum (300.13 MHz) 
 
 
 13C NMR spectrum (75.4 MHz) 
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6.1.4 NMR Spectrum of Cyathisterone (IV) 
 
 1H NMR spectrum (300.13 MHz) 
 
 
 13C NMR spectrum (75.4 MHz) 
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6.1.5 NMR Spectrum of Talarosterone (V) 
 
 1H NMR spectrum (300.13 MHz) 
 
 
 13C NMR spectrum (75.4 MHz) 
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6.1.6 NMR Spectrum of Emodin (VI) 
 
 1H NMR spectrum (500.13 MHz) 
 
 
 13C NMR spectrum (125.4 MHz) 
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6.1.7 NMR Spectrum of Questinol (VII) 
 
 1H NMR spectrum (300.13 MHz) 
 
 
 13C NMR spectrum (75.4 MHz) 
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6.1.8 NMR Spectrum of Citreorosein (VIII) 
 
 1H NMR spectrum (500.13 MHz) 
 
 
 13C NMR spectrum (125.4 MHz) 
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6.1.9 NMR Spectrum of Fallacinol (IX) 
 
 1H NMR spectrum (500.13 MHz) 
 
 
 13C NMR spectrum (125.4 MHz) 
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6.1.10 NMR Spectrum of Rheoemodin (X) 
 
 1H NMR spectrum (300.13 MHz) 
 
 
 13C NMR spectrum (75.4 MHz) 
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6.1.11 NMR Spectrum of Secalonic Acid A (XI) 
 
 1H NMR spectrum (300.13 MHz) 
 
 
 13C NMR spectrum (75.4 MHz) 
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6.1.12 NMR Spectrum of Bis- Anthraquinone (XII) 
 
 1H NMR spectrum (500.13 MHz) 
 
 
 13C NMR spectrum (125.4 MHz) 
 
 
 
		
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 7 
 
 
 
  
		
	
122	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
7. References 
 
Adams, P. B. (1990). The Potential of Mycoparasites for Biological Control of Plant 
Diseases*. Annual review of phytopathology 28, 59-72. 
Arai, M., Tomoda, H., Okuda, T., Wang, H., Tabata, N., Masuma, R., Yamaguchi, Y., and 
Omura, S. (2002). Funicone-related Compounds, Potentiators of Antifungal 
Miconazole Activity, Produced by Talaromyces flavus FKI-0076. The Journal of 
antibiotics 55, 172-180. 
Atalay, A., Koc, A. N., Akyol, G., Cakır, N., Kaynar, L., and Ulu-Kilic, A. (2016). Pulmonary 
infection caused by Talaromyces purpurogenus in a patient with multiple myeloma. 
Le infezioni in medicina: rivista periodica di eziologia, epidemiologia, diagnostica, 
clinica e terapia delle patologie infettive 24, 153. 
Ayer, W. A., and Racok, J. S. (1990). The metabolites of Talaromyces flavus: Part 1. 
Metabolites of the organic extracts. Canadian journal of chemistry 68, 2085-2094. 
Aziz, N. H., Mattar, Z. A., and Mahrous, S. R. (2006). Contamination of Grains by Mycotoxin-
Producing Molds and Mycotoxins and Control by Gamma Irradiation. Journal of food 
safety 26, 184-201. 
Bao, J., Sun, Y.-L., Zhang, X.-Y., Han, Z., Gao, H.-C., He, F., Qian, P.-Y., and Qi, S.-H. 
(2013). Antifouling and antibacterial polyketides from marine gorgonian coral-
associated fungus Penicillium sp. SCSGAF 0023. The Journal of antibiotics 66, 219-
223. 
Bara, R., Aly, A. H., Pretsch, A., Wray, V., Wang, B., Proksch, P., and Debbab, A. (2013a). 
Antibiotically active metabolites from Talaromyces wortmannii, an endophyte of Aloe 
vera. Journal of Antibiotics 66, 491. 
Bara, R., Aly, A. H., Wray, V., Lin, W., Proksch, P., and Debbab, A. (2013b). Talaromins A 
and B, new cyclic peptides from the endophytic fungus Talaromyces wortmannii. 
Tetrahedron Letters 54, 1686-1689. 
Bara, R., Zerfass, I., Aly, A. H., Goldbach-Gecke, H., Raghavan, V., Sass, P., Mándi, A., 
Wray, V., Polavarapu, P. L., and Pretsch, A. (2013c). Atropisomeric 
dihydroanthracenones as inhibitors of multiresistant Staphylococcus aureus. 
Journal of medicinal chemistry 56, 3257-3272. 
Benjamin, C. R. (1955). Ascocarps of Aspergillus and Penicillium. Mycologia 47, 669-687. 
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H., and Prinsep, M. R. (2015). Marine 
natural products. Natural Product Reports 32, 116-211. 
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H., and Prinsep, M. R. (2016). Marine 
natural products. Natural Product Reports 33, 382-431. 
		
	
123	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
Boosalis, M. (1956). Effect of soil temperature and green-manure amendment of 
unsterilized soil on parasitism of Rhizoctonia solani by Penicillium vermiculatum and 
Trichoderma sp. Phytopathology 46, 473-478. 
Bugni, T. S., and Ireland, C. M. (2004a). Marine-derived fungi: a chemically and biologically 
diverse group of microorganisms. Nat Prod Rep 21, 143-63. 
Bugni, T. S., and Ireland, C. M. (2004b). Marine-derived fungi: a chemically and biologically 
diverse group of microorganisms. Natural Product Reports 21, 143-163. 
Butler, M. S. (2004). The role of natural product chemistry in drug discovery. Journal of 
natural products 67, 2141-2153. 
Cantrell, C. L., Rajab, M. S., Franzblau, S. G., Fronczek, F. R., and Fischer, N. H. (1999). 
Antimycobacterial ergosterol-5, 8-endoperoxide from Ajuga remota. Planta medica 
65, 732-734. 
Carte, B. K. (1996). Biomedical potential of marine natural products. Bioscience 46, 271-
286. 
Castro, M., Preto, M., Vasconcelos, V., and Urbatzka, R. (2016). Obesity: The Metabolic 
Disease, Advances on Drug Discovery and Natural Product Research. Current 
topics in medicinal chemistry 16, 2577-2604. 
Choudhary, M. I. (2011). "Anti-Obesity Drug Discovery and Development," Bentham 
Science Publishers. 
Cohen, P. A., and Towers, G. N. (1995). The anthraquinones of Heterodermia obscurata. 
Phytochemistry 40, 911-915. 
Cruz, L. J., Insua, M. M., Baz, J. P., Trujillo, M., Rodriguez-Mias, R. A., Oliveira, E., Giralt, 
E., Albericio, F., and Canedo, L. M. (2006). IB-01212, a new cytotoxic 
cyclodepsipeptide isolated from the marine fungus Clonostachys sp. ESNA-A009. 
The Journal of organic chemistry 71, 3335-3338. 
Dijksterhuis, J. (2007). Heat-resistant ascospores. Mycology Series 25, 101. 
Ding, H.-E., Yang, Z.-D., Sheng, L., Zhou, S.-Y., Li, S., Yao, X.-J., Zhi, K.-K., Wang, Y.-G., 
and Zhang, F. (2015a). Secovironolide, a novel furanosteroid scaffold with a five-
membered B ring from the endophytic fungus Talaromyces wortmannii LGT-4. 
Tetrahedron Letters 56, 6754-6757. 
Ding, L.-J., Gu, B.-B., Jiao, W.-H., Yuan, W., Li, Y.-X., Tang, W.-Z., Yu, H.-B., Liao, X.-J., 
Han, B.-N., and Li, Z.-Y. (2015b). New Furan and Cyclopentenone Derivatives from 
the Sponge-Associated Fungus Hypocrea Koningii PF04. Marine drugs 13, 5579-
5592. 
Dong, Y., Lin, J., Lu, X., Zheng, Z., Ren, X., Zhang, H., He, J., and Yang, J. (2009). 
Cathepsin B inhibitory tetraene lactones from the fungus Talaromyces wortmannii. 
Helvetica Chimica Acta 92, 567-574. 
		
	
124	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
Dong, Y., Yang, J., Zhang, H., Lin, J., Ren, X., Liu, M., Lu, X., and He, J. (2006). 
Wortmannilactones AD, 22-Membered Triene Macrolides from Talaromyces 
wortmannii. Journal of natural products 69, 128-130. 
Duarte, K., Rocha-Santos, T. A., Freitas, A. C., and Duarte, A. C. (2012). Analytical 
techniques for discovery of bioactive compounds from marine fungi. TrAC Trends in 
Analytical Chemistry 34, 97-110. 
Dufosse, L., Fouillaud, M., Caro, Y., Mapari, S. A., and Sutthiwong, N. (2014). Filamentous 
fungi are large-scale producers of pigments and colorants for the food industry. 
Current opinion in biotechnology 26, 56-61. 
Enigl, D., King, A., and Török, T. (1993). Talaromyces trachyspermus, a heat-resistant mold 
isolated from fruit juice. Journal of Food Protection® 56, 1039-1042. 
Firn, R. D., and Jones, C. G. (2000). The evolution of secondary metabolism–a unifying 
model. Molecular microbiology 37, 989-994. 
Fleming, A. (1944). The discovery of penicillin. British Medical Bulletin 2, 4-5. 
Frisvad, J., and Filtenborg, O. (1988). Specific Mycotoxin Producing Penicillium and 
Aspergillus Mycoflora of Different Foods. Japanese Society of Mycotoxicology 1988, 
163-166. 
Frisvad, J., Filtenborg, O., Samson, R., and Stolk, A. (1990). Chemotaxonomy of the genus 
Talaromyces. Antonie van Leeuwenhoek 57, 179-189. 
Frisvad, J. C., Yilmaz, N., Thrane, U., Rasmussen, K. B., Houbraken, J., and Samson, R. 
A. (2013). Talaromyces atroroseus, a new species efficiently producing industrially 
relevant red pigments. PloS one 8, e84102. 
Fujii, T., Hoshino, T., Inoue, H., and Yano, S. (2014). Taxonomic revision of the cellulose-
degrading fungus Acremonium cellulolyticus nomen nudum to Talaromyces based 
on phylogenetic analysis. FEMS microbiology letters 351, 32-41. 
Fujimoto, H., Matsudo, T., Yamaguchi, A., and Yamazaki, M. (1990). Two new fungal 
azaphilones from Talaromyces luteus, with monoamine oxidase inhibitory effect. 
Heterocycles 30, 607-616. 
Fujimoto, H., Nakamura, E., Okuyama, E., and Ishibashi, M. (2004). Six 
immunosuppressive features from an ascomycete, Zopfiella longicaudata, found in 
a screening study monitored by immunomodulatory activity. Chemical and 
pharmaceutical bulletin 52, 1005-1008. 
Galeano, E., Rojas, J. J., and Martinez, A. (2011). Pharmacological developments obtained 
from marine natural products and current pipeline perspective. Natural product 
communications 6, 287-300. 
		
	
125	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
Gao, J., Shen, J., Zhang, A., Zhu, W., Zhang, X., and Liu, J. (2003). Chemical constituents 
of the fungus Leccinum extremiorientale. Chinese Journal of Organic Chemistry 23, 
853-857. 
Giacomotto, J., and Ségalat, L. (2010). High-throughput screening and small animal 
models, where are we? British journal of pharmacology 160, 204-216. 
Gill, M., and Steglich, W. (1987). Pigments of fungi (macromycetes). Natural Product 
Reports 51. 
Goel, R., Das, G. G., Ram, S., and Pandey, V. (1991). Antiulcerogenic and anti-
inflammatory effects of emodin, isolated from Rhamnus triquerta wall. Indian journal 
of experimental biology 29, 230-232. 
Gottlieb, D., and Van Etten, J. L. (1964). Biochemical changes during the growth of fungi I. 
Nitrogen Compounds and Carbohydrate Changes in Penicillium atrovenetum. 
Journal of bacteriology 88, 114-121. 
Gu, X.-l., and Tian, Y.-p. (2013). Isolation and characterization of urethanase from 
Penicillium variabile and its application to reduce ethyl carbamate contamination in 
Chinese rice wine. Applied biochemistry and biotechnology 170, 718-728. 
Hamilton, G. R., and Baskett, T. F. (2000). In the arms of Morpheus: the development of 
morphine for postoperative pain relief. Canadian journal of anesthesia 47, 367-374. 
Harvey, A. L. (2008). Natural products in drug discovery. Drug discovery today 13, 894-901. 
Hashimoto, M., Wakana, D., Ueda, M., Kobayashi, D., Goda, Y., and Fujii, I. (2015). Product 
identification of non-reducing polyketide synthases with C-terminus 
methyltransferase domain from Talaromyces stipitatus using Aspergillus oryzae 
heterologous expression. Bioorganic & medicinal chemistry letters 25, 1381-1384. 
Hawas, U. W., El-Beih, A. A., and El-Halawany, A. M. (2012). Bioactive anthraquinones 
from endophytic fungus Aspergillus versicolor isolated from red sea algae. Archives 
of pharmacal research 35, 1749-1756. 
He, J.-W., Liang, H.-X., Gao, H., Kuang, R.-Q., Chen, G.-D., Hu, D., Wang, C.-X., Liu, X.-
Z., Li, Y., and Yao, X.-S. (2014a). Talaflavuterpenoid A, a new nardosinane-type 
sesquiterpene from Talaromyces flavus. Journal of Asian natural products research 
16, 1029-1034. 
He, J.-W., Mu, Z.-Q., Gao, H., Chen, G.-D., Zhao, Q., Hu, D., Sun, J.-Z., Li, X.-X., Li, Y., 
and Liu, X.-Z. (2014b). New polyesters from Talaromyces flavus. Tetrahedron 70, 
4425-4430. 
He, J.-W., Qin, D.-P., Gao, H., Kuang, R.-Q., Yu, Y., Liu, X.-Z., and Yao, X.-S. (2014c). Two 
New Coumarins from Talaromyces flavus. Molecules 19, 20880-20887. 
Hirata, Y., and Uemura, D. (1986). Halichondrins-antitumor polyether macrolides from a 
marine sponge. Pure and Applied Chemistry 58, 701-710. 
		
	
126	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
Honda, N. K., Devincenzi, I. A., and Xavier Filho, L. (1995). Secalonic Acid A from 
Pseudoparmelia sphaerospora (Nyl.) Hale and Pseudoparmelia. hypomilta (Fée) 
Hale (Parmeliaceae). Tropical Bryology 10, 201-204. 
Horré, R., Gilges, S., Breig, P., Kupfer, B., De Hoog, G., Hoekstra, E., Poonwan, N., and 
Schaal, K. (2001). Case report. Fungaemia due to Penicillium piceum, a member of 
the Penicillium marneffei complex. Mycoses 44, 502-504. 
Hu, Y., Chen, J., Hu, G., Yu, J., Zhu, X., Lin, Y., Chen, S., and Yuan, J. (2015). Statistical 
research on the bioactivity of new marine natural products discovered during the 28 
years from 1985 to 2012. Marine Drugs 13, 202-21. 
Huang, H., Bremer, E., Hynes, R., and Erickson, R. (2000). Foliar application of fungal 
biocontrol agents for the control of white mold of dry bean caused by Sclerotinia 
sclerotiorum. Biological Control 18, 270-276. 
Huang, R., Wang, T., Xie, X.-S., Ma, K.-X., Fang, X.-W., and Wu, S.-H. (2016). Secondary 
Metabolites from an Endophytic Fungus Nigrospora sp. Chemistry of Natural 
Compounds 52, 697-699. 
Jayasuriya, H., Koonchanok, N. M., Geahlen, R. L., McLaughlin, J. L., and Chang, C.-J. 
(1992). Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum. 
Journal of Natural Products 55, 696-698. 
Jennings, D. (1983). Some aspects of the physiology and biochemistry of marine fungi. 
Biological Reviews 58, 423-459. 
Jin, L., Quan, C., Hou, X., and Fan, S. (2016). Potential Pharmacological Resources: 
Natural Bioactive Compounds from Marine-Derived Fungi. Marine Drugs 14. 
Jones, D., Anderson, H., Russell, J., Fraser, A., and Onions, A. H. (1984). Vermiculine, a 
metabolic product from Talaromyces wortmannii. Transactions of the British 
Mycological Society 83, 718-721. 
Jones, E., Sakayaroj, J., Suetrong, S., Somrithipol, S., and Pang, K. (2009). Classification 
of marine Ascomycota, anamorphic taxa and Basidiomycota. Fungal Diversity 35, 
187. 
Jones, K. S., Alimov, A. P., Rilo, H. L., Jandacek, R. J., Woollett, L. A., and Penberthy, W. 
T. (2008). A high throughput live transparent animal bioassay to identify non-toxic 
small molecules or genes that regulate vertebrate fat metabolism for obesity drug 
development. Nutrition & metabolism 5, 23. 
Kakvan, N., Heydari, A., Zamanizadeh, H. R., Rezaee, S., and Naraghi, L. (2013). 
Development of new bioformulations using Trichoderma and Talaromyces fungal 
antagonists for biological control of sugar beet damping-off disease. Crop Protection 
53, 80-84. 
		
	
127	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
Kawahara, N., Sekita, S., and Satake, M. (1994). Steroids from Calvatia cyathiformis. 
Phytochemistry 37, 213-215. 
Kijjoa, A., and Sawangwong, P. (2004). Drugs and cosmetics from the sea. Marine Drugs 
2, 73-82. 
Kim, D.-H., Jung, S. J., Chung, I.-S., Lee, Y.-H., Kim, D.-K., Kim, S.-H., Kwon, B.-M., Jeong, 
T.-S., Park, M.-H., and Seoung, N.-S. (2005). Ergosterol peroxide from flowers of 
Erigeron annuus L. as an anti-atherosclerosis agent. Archives of pharmacal 
research 28, 541-545. 
Kim, S.-W., Park, S.-S., Min, T.-J., and Yu, K.-H. (1999). Antioxidant activity of ergosterol 
peroxide (5, 8-epidioxy-5α, 8α-ergosta-6, 22E-dien-3β-ol) in Armillariella mellea. 
Bulletin Korean Chemical Society 20, 819-823. 
Kobayashi, M., Krishna, M. M., Ishida, K., and Anjaneyulu, V. (1992). Marine Sterols. XXII. 
Occurrence of 3-Oxo-4, 6, 8 (14)-triunsaturated Steroids in the Sponge Dvsidea 
herbacea. Chemical and pharmaceutical bulletin 40, 72-74. 
Koehn, F. E., and Carter, G. T. (2005). The evolving role of natural products in drug 
discovery. Nature reviews Drug discovery 4, 206-220. 
Kohlmeyer, J., and Kohlmeyer, E. (1979). Marine Mycology: The Higher Fungi (Academic, 
New York). KohlmeyerMarine Mycology: The Higher Fungi1979. 
Koski, R. R. (2008). Omega-3-acid ethyl esters (Lovaza) for severe hypertriglyceridemia. 
Pharmacy and Therapeutics 33, 271. 
Kubanek, J., Jensen, P. R., Keifer, P. A., Sullards, M. C., Collins, D. O., and Fenical, W. 
(2003). Seaweed resistance to microbial attack: a targeted chemical defense 
against marine fungi. Proceedings of the National Academy of Sciences 100, 6916-
6921. 
Kuml, D., Dethoup, T., Buttachon, S., Singburaudom, N., Silva, A., and Kijjoa, A. (2014). 
Spiculisporic acid E, a new spiculisporic acid derivative and ergosterol derivatives 
from the marine-sponge associated fungus Talaromyces trachyspermus (KUFA 
0021). Natural product communications 9, 1147-1150. 
Kurobane, I., Vining, L. C., and MCINNES, A. G. (1979). Biosynthetic relationships among 
the secalonic acids. The Journal of antibiotics 32, 1256-1266. 
Larsen, T. O., Smedsgaard, J., Nielsen, K. F., Hansen, M. E., and Frisvad, J. C. (2005). 
Phenotypic taxonomy and metabolite profiling in microbial drug discovery. Natural 
product reports 22, 672-695. 
Li, H., Huang, H., Shao, C., Huang, H., Jiang, J., Zhu, X., Liu, Y., Liu, L., Lu, Y., and Li, M. 
(2011). Cytotoxic norsesquiterpene peroxides from the endophytic fungus 
Talaromyces flavus isolated from the mangrove plant Sonneratia apetala. Journal 
of natural products 74, 1230-1235. 
		
	
128	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
Li, J. W.-H., and Vederas, J. C. (2009). Drug discovery and natural products: end of an era 
or an endless frontier? Science 325, 161-165. 
Lin, Y.-L., Wang, T.-H., Lee, M.-H., and Su, N.-W. (2008). Biologically active components 
and nutraceuticals in the Monascus-fermented rice: a review. Applied microbiology 
and biotechnology 77, 965-973. 
Link, E. M., Hardiman, G., Sluder, A. E., Johnson, C. D., and Liu, L. X. (2000). Therapeutic 
target discovery using Caenorhabditis elegans. Pharmacogenomics 1, 203-217. 
Lowenberg, B., Pabst, T., Vellenga, E., Farag, S., Ruppert, A., and Mrozek, K. (2011). 
Cytarabine dose for acute myeloid leukemia. New England Journal of Medicine 
2011, 2166-2169. 
Lynn, D. G., Phillips, N. J., Hutton, W. C., Shabanowitz, J., Fennell, D., and Cole, R. (1982). 
Talaromycins: application of homonuclear spin correlation maps to structure 
assignment. Journal of the American Chemical Society 104, 7319-7322. 
Madi, L., Katan, T., Katan, J., and Henis, Y. (1997). Biological control of Sclerotium rolfsii 
and Verticillium dahliae by Talaromyces flavus is mediated by different mechanisms. 
Phytopathology 87, 1054-1060. 
Manojlovic, N., Solujic, S., Sukdolak, S., and Krstic, L. (2000). Isolation and antimicrobial 
activity of anthraquinones from some species of the lichen genus Xanthoria. Jornal 
of the Serbian Chemical Society 65, 555-560. 
Manojlovic, N. T., Solujic, S., and Sukdolak, S. (2002). Antimicrobial activity of an extract 
and anthraquinones from Caloplaca schaereri. The Lichenologist 34, 83-85. 
Mapari, S. A., Hansen, M. E., Meyer, A. S., and Thrane, U. (2008). Computerized screening 
for novel producers of Monascus-like food pigments in Penicillium species. Journal 
of agricultural and food chemistry 56, 9981-9989. 
Marois, J., Fravel, D., and Papavizas, G. (1984). Ability of Talaromyces flavus to occupy 
the rhizosphere and its interaction with Verticillium dahliae. Soil Biology and 
Biochemistry 16, 387-390. 
Marois, J., Johnston, S., Dunn, M., and Papavizas, G. (1982). Biological control of 
Verticillium wilt of eggplant in the field. Plant Disease 66, 1166-1168. 
Martinez, M. (2016). Ergosterol from the mushroom laetiporus sp.; isolation and structural 
characterization. Revista Boliviana de Química 32. 
Martins, A., Vieira, H., Gaspar, H., and Santos, S. (2014). Marketed marine natural products 
in the pharmaceutical and cosmeceutical industries: Tips for success. Marine drugs 
12, 1066-1101. 
Mayer, A. M., Glaser, K. B., Cuevas, C., Jacobs, R. S., Kem, W., Little, R. D., McIntosh, J. 
M., Newman, D. J., Potts, B. C., and Shuster, D. E. (2010). The odyssey of marine 
		
	
129	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
pharmaceuticals: a current pipeline perspective. Trends in pharmacological 
sciences 31, 255-265. 
McLaren, D., Huang, H., and Rimmer, S. (1986). Hyperparasitism of Sclerotinia 
sclerotiorum by Talaromyces flavus. Canadian Journal of Plant Pathology 8, 43-48. 
Moulé, Y., Douce, C., Moreau, S., and Darracq, N. (1981). Effects of the mycotoxin 
botryodiplodin on mammalian cells in culture. Chemico-biological interactions 37, 
155-164. 
Murakami, T. (1956). The coloring matters of Xanthoria fallax (HEPP.) ARN. Fallacinal and 
fallacinol. Pharmaceutical bulletin 4, 298-302. 
Naraghi, L., Heydari, A., and Ershad, D. (2006). Sporulation and survival of Talaromyces 
flavus on different plant material residues for biological control of cotton wilt caused 
by Verticillium dahliae. Iranian Journal of Plant Pathology 42. 
Naraghi, L., Heydari, A., Rezaee, S., and Razavi, M. (2012). Biocontrol agent Talaromyces 
flavus stimulates the growth of cotton and potato. Journal of plant growth regulation 
31, 471-477. 
Naraghi, L., Heydari, A., Rezaee, S., Razavi, M., and Afshari-Azad, H. (2011). Biological 
control of Verticillium wilt of greenhouse cucumber by Talaromyces flavus. 
Phytopathologia Mediterranea 49, 321-329. 
Naraghi, L., Heydari, A., Rezaee, S., Razavi, M., and Jahanifar, H. (2010). Study on 
antagonistic effects of Talaromyces flavus on Verticillium albo-atrum, the causal 
agent of potato wilt disease. Crop Protection 29, 658-662. 
Narikawa, T., Shinoyama, H., and Fujii, T. (2000). A β-rutinosidase from Penicillium 
rugulosum IFO 7242 that is a peculiar flavonoid glycosidase. Bioscience, 
biotechnology, and biochemistry 64, 1317-1319. 
Newman, D. J., and Cragg, G. M. (2014). Marine-sourced anti-cancer and cancer pain 
control agents in clinical and late preclinical development. Marine drugs 12, 255-
278. 
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., 
Biryukov, S., Abbafati, C., and Abera, S. F. (2014). Global, regional, and national 
prevalence of overweight and obesity in children and adults during 1980–2013: a 
systematic analysis for the Global Burden of Disease Study 2013. The Lancet 384, 
766-781. 
Nicoletti, R., Manzo, E., and Ciavatta, M. L. (2009). Occurence and bioactivities of funicone-
related compounds. International journal of molecular sciences 10, 1430-1444. 
Nicoletti, R., and Trincone, A. (2016). Bioactive compounds produced by strains of 
Penicillium and Talaromyces of marine origin. Marine drugs 14, 37. 
		
	
130	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
Osmanova, N., Schultze, W., and Ayoub, N. (2010). Azaphilones: a class of fungal 
metabolites with diverse biological activities. Phytochemistry Reviews 9, 315-342. 
Petruzzi, L., Bevilacqua, A., Ciccarone, C., Gambacorta, G., Irlante, G., Lamacchia, C., and 
Sinigaglia, M. (2012). Artificial aging of Uva di Troia and Primitivo wines using oak 
chips inoculated with Penicillium purpurogenum. Journal of the Science of Food and 
Agriculture 92, 343-350. 
Petzinger, E., and Weidenbach, A. (2002). Mycotoxins in the food chain: the role of 
ochratoxins. Livestock Production Science 76, 245-250. 
Phillips, N., Cole, R., and Lynn, D. (1987). Talaromycins C, D, E, and F. Tetrahedron letters 
28, 1619-1621. 
Piattelli, M., and de Nicola, M. G. (1968). Anthraquinone pigments from Xanthoria parientina 
(L.). Phytochemistry 7, 1183-1187. 
Pitt, J. I., and Hocking, A. D. (2009). "Fungi and food spoilage," Springer. 
Pitt, J. I., Samson, R. A., and Frisvad, J. C. (2000). List of accepted species and their 
synonyms in the family Trichocomaceae. 
Pol, D., Laxman, R. S., and Rao, M. (2012). Purification and biochemical characterization 
of endoglucanase from Penicillium pinophilum MS 20. Indian Journal of 
Biochemistry & Biophysics. 
Proksch, P., Ebel, R., Edrada, R., Riebe, F., Liu, H., Diesel, A., Bayer, M., Li, X., Han Lin, 
W., Grebenyuk, V., Müller, W. E. G., Draeger, S., Zuccaro, A., and Schulz, B. (2008). 
Sponge-associated fungi and their bioactive compounds: the Suberites case. 
Botanica Marina 51. 
Prompanya, C., Fernandes, C., Cravo, S., Pinto, M. M., Dethoup, T., Silva, A., and Kijjoa, 
A. (2015). A new cyclic hexapeptide and a new isocoumarin derivative from the 
marine sponge-associated fungus Aspergillus similanensis KUFA 0013. Marine 
drugs 13, 1432-1450. 
Quang, D. N., Hashimoto, T., Nomura, Y., Wollweber, H., Hellwig, V., Fournier, J., Stadler, 
M., and Asakawa, Y. (2005). Cohaerins A and B, azaphilones from the fungus 
Hypoxylon cohaerens, and comparison of HPLC-based metabolite profiles in 
Hypoxylon sect. Annulata. Phytochemistry 66, 797-809. 
Raghukumar, C. (2008). Marine fungal biotechnology: an ecological perspective. Fungal 
Diversity 31, 19-35. 
Rateb, M. E., and Ebel, R. (2011). Secondary metabolites of fungi from marine habitats. 
Natural product reports 28, 290-344. 
Reyes, I., Bernier, L., Simard, R. R., Tanguay, P., and Antoun, H. (1999). Characteristics of 
phosphate solubilization by an isolate of a tropical Penicillium rugulosum and two 
UV-induced mutants. FEMS Microbiology Ecology 28, 291-295. 
		
	
131	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
Rinehart, K. L., Holt, T. G., Fregeau, N. L., Stroh, J. G., Keifer, P. A., Sun, F., Li, L. H., and 
Martin, D. G. (1990). Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent 
antitumor agents from the Caribbean tunicate Ecteinascidia turbinata. The Journal 
of Organic Chemistry 55, 4512-4515. 
Roh, C., and Jung, U. (2012). Screening of crude plant extracts with anti-obesity activity. 
International Journal of Molecular Sciences 13, 1710-1719. 
Rollinger, J. M., Stuppner, H., and Langer, T. (2008). Virtual screening for the discovery of 
bioactive natural products. In "Natural Compounds as Drugs Volume I", pp. 211-
249. Springer. 
Ruiz-Ojeda, F. J., Rupérez, A. I., Gomez-Llorente, C., Gil, A., and Aguilera, C. M. (2016). 
Cell models and their application for studying adipogenic differentiation in relation to 
obesity: a review. International Journal of Molecular Sciences 17, 1040. 
Sakai, A., Tanaka, H., Konishi, Y., Hanazawa, R., Ota, T., Nakahara, Y., Sekiguchi, S., 
Oshida, E., Takino, M., and Ichinoe, M. (2005). Mycological examination of domestic 
unpolished rice and mycotoxin production by isolated Penicillium islandicum. 
Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan 46, 205-
212. 
Saleem, M., Ali, M. S., Hussain, S., Jabbar, A., Ashraf, M., and Lee, Y. S. (2007). Marine 
natural products of fungal origin. Natural product reports 24, 1142-1152. 
Santos, P., Piontelli, E., Shea, Y., Galluzzo, M., Holland, S., Zelazko, M., and Rosenzweig, 
S. (2006). Penicillium piceum infection: diagnosis and successful treatment in 
chronic granulomatous disease. Medical mycology 44, 749-753. 
Schafhauser, T., Wibberg, D., Rückert, C., Winkler, A., Flor, L., van Pée, K.-H., Fewer, D. 
P., Sivonen, K., Jahn, L., and Ludwig-Müller, J. (2015). Draft genome sequence of 
Talaromyces islandicus (“Penicillium islandicum”) WF-38-12, a neglected mold with 
significant biotechnological potential. Journal of biotechnology 211, 101-102. 
Schmidtko, A., Lötsch, J., Freynhagen, R., and Geisslinger, G. (2010). Ziconotide for 
treatment of severe chronic pain. The Lancet 375, 1569-1577. 
Schueffler, A., and Anke, T. (2014). Fungal natural products in research and development. 
Natural product reports 31, 1425-1448. 
Scott, V. N., and Bernard, D. T. (1987). Heat resistance of Talaromyces flavus and 
Neosartorya fischeri isolated from commercial fruit juices. Journal of Food 
Protection® 50, 18-20. 
Senter, P. D., and Sievers, E. L. (2012). The discovery and development of brentuximab 
vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell 
lymphoma. Nature biotechnology 30, 631-637. 
		
	
132	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
Sheldrick, G. M. (2008). A short history of SHELX. Acta Crystallographica Section A: 
Foundations of Crystallography 64, 112-122. 
Shiozawa, H., Takahashi, M., Takatsu, T., Kinoshita, T., Tanzawa, K., Hosoya, T., Furuya, 
K., Takahashi, S., Furihata, K., and Seto, H. (1995). Trachyspic acid, a new 
metabolite produced by Talaromyces trachyspermus, that inhibits tumor cell 
heparanase: taxonomy of the producing strain, fermentation, isolation, structural 
elucidation, and biological activity. The Journal of antibiotics 48, 357-362. 
Shulman, J. M., Shulman, L. M., Weiner, W. J., and Feany, M. B. (2003). From fruit fly to 
bedside: translating lessons from Drosophila models of neurodegenerative disease. 
Current opinion in neurology 16, 443-449. 
Sigler, L., Abbott, S., and Frisvad, J. (1996). Rubratoxin mycotoxicosis by Penicillium 
crateriforme following ingestion of homemade rhubarb wine. In "Abstracts, 96th 
ASM, New Orleans. F-22", pp. 77. 
Singh, J. (1999). Ethnomycology and folk remedies: Fact and fiction. In "From 
Ethnomycology to Fungal Biotechnology", pp. 11-17. Springer. 
Singh, J., and Aneja, K. (2012). "From ethnomycology to fungal biotechnology: exploiting 
fungi from natural resources for novel products," Springer Science & Business 
Media. 
Singh, S. B., Jayasuriya, H., Dewey, R., Polishook, J. D., Dombrowski, A. W., Zink, D. L., 
Guan, Z., Collado, J., Platas, G., and Pelaez, F. (2003). Isolation, structure, and 
HIV-1-integrase inhibitory activity of structurally diverse fungal metabolites. Journal 
of Industrial Microbiology and Biotechnology 30, 721-731. 
Speakman, J., Hambly, C., Mitchell, S., and Król, E. (2008). The contribution of animal 
models to the study of obesity. Laboratory animals 42, 413-432. 
Steglich, W., Fugmann, B., and Lang-Fugmann, S. (2000). "Römpp encyclopedia natural 
products," Georg Thieme Verlag. 
Stodůlková, E., Kolařík, M., Křesinová, Z., Kuzma, M., Šulc, M., Man, P., Novák, P., Maršík, 
P., Landa, P., and Olšovská, J. (2009). Hydroxylated anthraquinones produced by 
Geosmithia species. Folia microbiologica 54, 179-187. 
Stolk, A. C., and Samson, R. A. (1972). "The genus Talaromyces: studies on Talaromyces 
and related genera," Centraalbureau voor Schimmelcultures. 
Stosz, S. K., Fravel, D. R., and Roberts, D. P. (1996). In vitro analysis of the role of glucose 
oxidase from Talaromyces flavus in biocontrol of the plant pathogen Verticillium 
dahliae. Applied and environmental microbiology 62, 3183-3186. 
Supparatpinyo, K., Perriens, J., Nelson, K. E., and Sirisanthana, T. (1998). A controlled trial 
of itraconazole to prevent relapse of Penicillium marneffei infection in patients 
		
	
133	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
infected with the human immunodeficiency virus. New England Journal of Medicine 
339, 1739-1743. 
Tabata, Y., Ikegami, S., Yaguchi, T., Sasaki, T., Hoshiko, S., Sakuma, S., SFFIN-YA, K., 
and Seto, H. (1999). Diazaphilonic acid, a new azaphilone with telomerase inhibitory 
activity. The Journal of antibiotics 52, 412-414. 
Takeuchi, M., Nakajima, M., Ogita, T., Inukai, M., Kodama, K., Furuya, K., Nagaki, H., and 
Haneishi, T. (1989). Fosfonochlorin, a new antibiotic with spheroplast forming 
activity. The Journal of antibiotics 42, 198-205. 
Tan, N., Cai, X.-L., Wang, S.-Y., Pan, J.-H., Tao, Y.-W., She, Z.-G., Zhou, S.-N., Lin, Y.-C., 
and Vrijmoed, L. L. (2008). A new hTopo I isomerase inhibitor produced by a 
mangrove endophytic fungus no. 2240. Journal of Asian natural products research 
10, 607-610. 
Thomas, T. R. A., Kavlekar, D. P., and LokaBharathi, P. A. (2010). Marine drugs from 
sponge-microbe association—A review. Marine Drugs 8, 1417-1468. 
Turner, W. B. (1971). Fungal metabolites. Journal of Pharmaceutical Sciences 73. 
Tzeng, T.-F., Lu, H.-J., Liou, S.-S., Chang, C. J., and Liu, I.-M. (2012). Emodin, a naturally 
occurring anthraquinone derivative, ameliorates dyslipidemia by activating AMP-
activated protein kinase in high-fat-diet-fed rats. Evidence-Based Complementary 
and Alternative Medicine 2012. 
Udagawa, S., and Tatsuno, T. (2003). Safety of rice grains and mycotoxins-a historical 
review of yellow rice mycotoxicoses. Yakushigaku zasshi 39, 321-342. 
Unson, M., Holland, N., and Faulkner, D. (1994). A brominated secondary metabolite 
synthesized by the cyanobacterial symbiont of a marine sponge and accumulation 
of the crystalline metabolite in the sponge tissue. Marine Biology 119, 1-11. 
Usher, K., Fromont, J., Sutton, D., and Toze, S. (2004). The biogeography and phylogeny 
of unicellular cyanobacterial symbionts in sponges from Australia and the 
Mediterranean. Microbial ecology 48, 167-177. 
Verdaguer, H., Morilla, I., and Urruticoechea, A. (2013). Eribulin mesylate in breast cancer. 
Women’s Health 9, 517-526. 
Vogel, G. (2000). Zebrafish earns its stripes in genetic screens. Science 288, 1160-1161. 
Wada, S. i., Usami, I., Umezawa, Y., Inoue, H., Ohba, S. i., Someno, T., Kawada, M., and 
Ikeda, D. (2010). Rubratoxin A specifically and potently inhibits protein phosphatase 
2A and suppresses cancer metastasis. Cancer science 101, 743-750. 
Wang, P.-L., Li, D.-Y., Xie, L.-R., Wu, X., Hua, H.-M., and Li, Z.-L. (2014). Two new 
compounds from a marine-derived fungus Penicillium oxalicum. Natural product 
research 28, 290-293. 
		
	
134	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
Wang, W., Zhu, T., Tao, H., Lu, Z., Fang, Y., Gu, Q., and Zhu, W. (2007). Two new cytotoxic 
quinone type compounds from the halotolerant fungus Aspergillus variecolor. 
Journal of Antibiotics 60, 603. 
Wase, N. V., and Wright, P. C. (2008). Systems biology of cyanobacterial secondary 
metabolite production and its role in drug discovery. Expert opinion on drug 
discovery 3, 903-929. 
Wei, X., Jiang, J.-S., Feng, Z.-M., and Zhang, P.-C. (2008). Anthraquinone-
benzisochromanquinone dimers from the roots of Berchemia floribunda. Chemical 
and Pharmaceutical Bulletin 56, 1248-1252. 
Weisenborn, J. L., Kirschner, R., Cáceres, O., and Piepenbring, M. (2010). Talaromyces 
indigoticus Takada & Udagawa, the First Record for Panama and the American 
Continent. Mycopathologia 170, 203-208. 
Whitley, R. J., Nahmias, A. J., Soong, S.-J., Galasso, G. G., Fleming, C. L., Alford, C. A., 
Connor, J., Bryson, Y., and Linnemann, C. (1980). Vidarabine therapy of neonatal 
herpes simplex virus infection. Pediatrics 66, 495-501. 
Wilkinson, C. (1978). Microbial associations in sponges. I. Ecology, physiology and 
microbial populations of coral reef sponges. Marine biology 49, 161-167. 
Wilkinson, C. C., and Garrone, R. R. (1980). Nutrition of marine sponges. Involvement of 
symbiotic bacteria in the uptake of dissolved carbon. Nutrition in the Lower Metazoa-
pages: 157-161. 
Wilkinson, C. C., Summons, R. R., and Evans, E. (1999). Nitrogen fixation in symbiotic 
marine sponges: ecological significance and difficulties in detection. Memoirs of the 
Queensland Museum 44, 667-673. 
Wu, B., Ohlendorf, B., Oesker, V., Wiese, J., Malien, S., Schmaljohann, R., and Imhoff, J. 
F. (2015). Acetylcholinesterase inhibitors from a marine fungus Talaromyces sp. 
strain LF458. Marine biotechnology 17, 110-119. 
Xu, L., Meng, W., Cao, C., Wang, J., Shan, W., and Wang, Q. (2015). Antibacterial and 
antifungal compounds from marine fungi. Marine drugs 13, 3479-3513. 
Yagi, A., Makino, K., and Nishioka, I. (1977). Studies on the constituents of Aloe saponaria 
HAW. II. The structures of tetrahydroanthracene derivatives, aloesaponol III and-IV. 
Chemical and Pharmaceutical Bulletin 25, 1764-1770. 
Yamazaki, M., Maebayashi, Y., and Miyaki, K. (1971). The isolation of secalonic acid A from 
Aspergillus ochraceus cultured on rice. Chemical and Pharmaceutical Bulletin 19, 
199-201. 
Yang, X., Kang, M.-C., Li, Y., Kim, E.-A., Kang, S.-M., and Jeon, Y.-J. (2014). Anti-
inflammatory activity of questinol isolated from marine-derived fungus Eurotium 
		
	
135	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
amstelodami in lipopolysaccharide-stimulated RAW 264.7 macrophages. Journal of 
Microbiology and Biotechnology 24, 1346-1353. 
Yang, Y.-C., Lim, M.-Y., and Lee, H.-S. (2003). Emodin isolated from Cassia obtusifolia 
(Leguminosae) seed shows larvicidal activity against three mosquito species. 
Journal of agricultural and food chemistry 51, 7629-7631. 
Yilmaz, N., Hagen, F., Meis, J. F., Houbraken, J., and Samson, R. A. (2016). Discovery of 
a sexual cycle in Talaromyces amestolkiae. Mycologia 108, 70-79. 
Yilmaz, N., Houbraken, J., Hoekstra, E., Frisvad, J. C., Visagie, C., and Samson, R. (2012). 
Delimitation and characterisation of Talaromyces purpurogenus and related 
species. Persoonia-Molecular Phylogeny and Evolution of Fungi 29, 39-54. 
Yilmaz, N., Visagie, C. M., Houbraken, J., Frisvad, J. C., and Samson, R. A. (2014). 
Polyphasic taxonomy of the genus Talaromyces. Studies in Mycology 78, 175-341. 
Yoshida, E., Fujimoto, H., and Yamazaki, M. (1996). Isolation of three new azaphilones, 
luteusins C, D, and E, from an ascomycete, talaromyces luteus. Chemical and 
pharmaceutical bulletin 44, 284-287. 
Younes, A., Yasothan, U., and Kirkpatrick, P. (2012). Brentuximab vedotin. Nature Reviews 
Drug Discovery 11, 19-20. 
Yun, J. W. (2010). Possible anti-obesity therapeutics from nature–A review. Phytochemistry 
71, 1625-1641. 
Zang, Y., Genta-Jouve, G., Retailleau, P., Escargueil, A., Mann, S., Nay, B., and Prado, S. 
(2016). Talaroketals A and B, unusual bis (oxaphenalenone) spiro and fused ketals 
from the soil fungus Talaromyces stipitatus ATCC 10500. Organic & biomolecular 
chemistry 14, 2691-2697. 
Zang, Y., Genta-Jouve, G., Sun, T. A., Li, X., Didier, B., Mann, S., Mouray, E., Larsen, A. 
K., Escargueil, A. E., Nay, B., and Prado, S. (2015). Unexpected talaroenamine 
derivatives and an undescribed polyester from the fungus Talaromyces stipitatus 
ATCC10500. Phytochemistry 119, 70-5. 
Zhai, M.-M., Li, J., Jiang, C.-X., Shi, Y.-P., Di, D.-L., Crews, P., and Wu, Q.-X. (2016). The 
Bioactive Secondary Metabolites from Talaromyces species. Natural products and 
bioprospecting 6, 1-24. 
Zhang, A.-L., Liu, L.-P., Wang, M., and Gao, J.-M. (2007). Bioactive ergosterol derivatives 
isolated from the fungus Lactarius hatsudake. Chemistry of Natural Compounds 43, 
637-638. 
Zhao, Y.-Y., Zhao, Y., Zhang, Y.-M., Lin, R.-C., and Sun, W.-J. (2009). Qualitative and 
quantitative analysis of the diuretic component ergone in Polyporus umbellatus by 
HPLC with fluorescence detection and HPLC-APCI-MS/MS. Die Pharmazie-An 
International Journal of Pharmaceutical Sciences 64, 366-370. 
		
	
136	
BIOACTIVE SECONDARY METABOLITES FROM THE CULTURE OF THE MARINE SPONGE-ASSOCIATED FUNGUS  
TALAROMYCES STIPITATUS KUFA 0207 
 
Zhou, Y., Debbab, A., Wray, V., Lin, W., Schulz, B., Trepos, R., Pile, C., Hellio, C., Proksch, 
P., and Aly, A. H. (2014). Marine bacterial inhibitors from the sponge-derived fungus 
Aspergillus sp. Tetrahedron Letters 55, 2789-2792. 
Zin, W. W. M., Buttachon, S., Buaruang, J., Gales, L., Pereira, J. A., Pinto, M. M., Silva, A., 
and Kijjoa, A. (2015). A new meroditerpene and a new tryptoquivaline analog from 
the algicolous fungus Neosartorya takakii KUFC 7898. Marine drugs 13, 3776-3790. 
		
 
